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This dissertation evaluates the neurotoxicity of lasalocid and the effect of 
phenylmethylsulfonyl fluoride on the modulation of lasalocid neurotoxicity in chickens 
and rats. Neurotoxicity of chemicals has been a challenging problem in modern society 
since a continuous exposure to environmental and man-made chemicals is an ever-
present problem. Use of toxicant specific neurotoxicity models and certain chemicals 
which have the ability of inducing modulation on specific neuropathies has been a 
valuable tool to investigate different neurotoxicities. Lasalocid, an ionophore antibiotic, 
has been related to a number of outbreaks of neurotoxicity cases in animal species. 
Phenylmethylsulfonyl fluoride is a serine protease inhibitor which has been widely 
utilized in the elucidation of organophosphate induced delayed neuropathy (OPIDN). 
Chapter I is a review of the literature of ionophores and OPIDN including the role of 
phenylmethylsulfonyl fluoride in the expression OPIDN. Chapter II deals with lasalocid 
neurotoxicity and modulation of lasalocid toxicity by PMSF in broiler chickens. The 
findings of these studies identify and characterize neuropathy with clinical symptoms, 
electrophysiology and histopathology in broiler chickens. Chapter III is concerned with 
dose-response studies with respect to lasalocid and describes lasalocid neuropathy in a rat 
model as well as the effect of PMSF on lasalocid neurotoxicity. 
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CHAPTER I 
INTRODUCTION AND LITERATURE REVIEW 
Introduction 
Neuropathies are common features of many diseases resulting from different 
etiologies. Among these, neuropathies associated with human immounodeficiency virus 
(HIV), diabetes mellitus, and chronic alcoholism are of special concern because of 
increasing incidence and some of the most frequent causes of neuropathies in human. In 
addition, there are numerous causes of peripheral neuropathies including hereditary, 
toxic, drug induced, inflammatory, ischemic and paraneoplastic (Ludoph and Spencer, 
1995; Tan et al., 1995; Srinivasan, et al., 2000). 
Lasalocid (LA) is a polyether antibiotic which is used to prevent coccidiosis in 
poultry and to increase feed efficiency in ruminants. When administered above 
therapeutic levels, LA can induce a peripheral neuropathy in broiler chickens. Clinical 
manifestation of this effect can cause ataxia known as duck walking syndrome (Gregory 
et al., 1995; Roder, 1996). 
Organophosphorus (OP) toxicants are another group of neuropathy inducing 
agents, used for many years as insecticides and related to several outbreaks of a 
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syndrome known as organophosphorus induced delayed neuropathy (OPIDN). In spite of 
extensive research and finding putative target enzyme for the initiation of OPIDN, 
current mechanistic explanations for OPIDN still lack convincing evidence. Methods to 
elucidate mechanism of the toxicity may include use of other chemicals which can 
potentiate or prevent toxicity (Lotti, 1992). Phenylmethylsulfonyl fluoride (PMSF) is one 
such agent which has been widely utilized in mechanistic studies of OPIDN. 
Neuropathies of different mechanism can be promoted by PMSF (Moretto et al., 1992). 
IONOPHORE ANTIBIOTICS 
Classification of Ionophores 
Ionophores as a class are divided into two general groups based on mode of ion 
transfer across membranes. These include channel formers and ion carriers. 
Channel formers 
Channel forming ionophores arrange themselves inside the membrane structure, 
creating a hydrophilic channel for the ions. By this means, ions from outside the cell pass 
through the provided hydrophilic channel into the cell. This mode of ion transport is 
analogous to that of transport proteins found in cell membranes. A well-known example 
of this type of ion transport is carried out by gramicidin. To form a channel within the 
membrane, two gramicidin molecules are required to line up across the membrane. When 
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two gramicidin molecules dimerize within the membrane, a hydrophilic channel is 
formed with outside consisting of hydrophobic residues (Becker, 1996; Pressman, 1976). 
Ion carriers 
Ion carriers can be subdivided into neutral ionophores and carboxylic ionophores. 
Regardless of subdivisions, both neutral and carboxylic ionophores move the ions across 
lipid bilayer by diffusing together with ions. These ion carriers act in a way that they bind 
the ions on one side of the cell membrane and allow the ion to sit within the ion carrier. 
The resulting complex moves across the lipid bilayer and releases the ion on the other 
side. Valinomycin, lasalocid, nigericin and A23187 are examples of ionophores with this 
mode of action (Becker, 1996; Pressman, 1976). In order to bind a metal cation, a 
carboxylic ionophore is required to be in deprotonated anionic form, and it must be in the 
protonated form (ionophore-H) or electrically neutral zwitterion form (I-Metal Ion) to 
diffuse across the membrane (Bergen and Bates, 1984). The movement of ions across the 
membranes depends on the concentration gradient of that ion. 
Chemistry of Lasalocid 
Lasalocid belongs to the subdivision of carboxylic ionophores. The molecular 
structure of lasalocid contains a tetrahydropyran and a tetrahydrofuran ring which give 
the name polyether antibiotic. It contains a terminal carboxyl group. All carboxylic 
ionophores posses linear backbones which contain heterocylic rings with oxygen 
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residues. For ion c omplexation, cyclic conformation of structure with oxygen residues 
inside and alkyl groups outside is required. When the resulting structure binds with the 
cation a lipid soluble complex is formed (Galitzer and Oehme, 1984). While the head of 
molecule contains a carboxyl group, the other end of the backbone carries one or two 
hydroxyl groups (at the tail). Among the carboxylic ionophores, lasalocid has the smallest 
structural backbone and is thought to form a shell-like structure. This structural 
orientation allows ions to sit on the molecule instead of placement inside the structure. 
It is thought that this structural property of lasalocid allows it to complex with a broad 
spectrum of cations and some organic amines as well (Pressman, 1976). The chemical 
structure of Lasalocid is shown in figure 1. 
COOH CH3 
HO 
~ OH CH CH 2 3 
HC 
3 CH3 
Figure 1. Chemical Structure of Lasalocid 
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Binding and Transport Selectiviy of Ionophores 
Different i onophores have varying degrees of affinity for different cations. For 
example, while monensin has much more affinity ( 10 times) for binding Na+ compared to 
K+, lasalocid shows greater affinity for K+ and equal affinity for both Na+ and Ca++. The 
relative affinity of monensin is Na+> K+> Lt> Rb+> Cs+ and for lasalocid K+> Rb+> 
Na+> Cs+> Lt. As noted above, lasalocid also binds divalent cations such as Ca++, Mg++, 
Ba++ (Elsasser, 1984; Bergen and Bates, 1984). The oxygens in the chemical structure of 
ionophores bind to cations through ion-dipole interaction much like a salvation of ions in 
high-dielectric solvents. The ion selectivity of ionophores is determined by the energy 
required for desolvation of the ion and the liganding energy attained upon complexation 
(Pressman, 1976). Interestingly, the transport rate of these ionophores may differ in their 
selective transfer of ions. For example, the order of relative selectivities for enhacement 
of membrane permeability oflasalocid is Ca++> Mg++> Na+> K+ (Gad et al., 1985). 
Use of Ionophores in Food Animal Production 
Improvement of feed efficiency and producing more lean protein with rapid 
growth at a lower cost has been primary objectives in animal husbandry. The most 
commonly used ionophores (Monensin, Lasalocid and Salinomycin) are incorporated into 
rations as anticoccidials in poultry and as growth promoters in ruminant feeding. The 
broad spectrum of antibacterial activity along with the ability of these compounds to 
passively transport cations across cell membranes is thought to be the basis of their 
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mechanism of action in the prevention of coccidiosis and improving feed efficiency of 
ruminants (Elsasser, 1984). 
Increase in feed efficiency can be achieved by ionophores via three different ways 
m ruminants. These include increased efficiency in energy metabolism, improved 
nitrogen metabolism in the rumen and prevention of lactic acidosis. Increase in feed 
efficiency is thought to be associated with increasing ruminal propionic acid and 
decreasing acetate and butyrate with resultant improvement of energy and carbon 
retention in the rumen. Improved nitrogen metabolism is attributed to increased quantity 
of dietary protein (Bergen and Bates, 1984). Use of lasalocid and monensin in cattle 
efficiently prevents lactic acidosis (Nagaraja et al., 1981). In the prevention of lactic 
acidosis, the effect of ionophores is observed by reducing the gram positive bacteria 
(responsible for producing ruminal lactate) and increasing the gram negatives (Bergen 
and Bates, 1984). 
Treatment of monensin, salinomycin, and lasalocid in chickens and turkeys 
significantly inhibited invasion of Eimeria sporozoites in cecal tissues (Augustine et al., 
1987). The protective effect of ionophores against coccidia is associated with the ability 
of these drugs to transport ions across biological membranes and altering ionic balance in 
coccidia (Augustine et al. 1992). 
Toxicity of Ionophores in Animals 
The toxicity of ionophores has been widely studied in a number of animal species. 
A number of toxicity cases have been reported in horses, cattle, sheep, cat, pig and avian 
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species (Galitzer, 1984, 1986; Hanson, 1981; Oehme and Pickrell, 1999; Van der Linde-
Sipman, 1999; Halvorson, 1982; Novilla, 1992). Ionophores are generally safe and 
effective if used at recommended levels. However, ionophore toxicity might occur due to 
accidental overdose, misuse and mixing errors in the ration (Novilla, 1992). 
Clinical and Pathological Aspects of Ionophore Toxicosis: 
Signs of ionophore toxicity comprise undefinite general symptoms. Most common 
signs of ionophore toxicity include anorexia, hypoactivity, leg weakness, ataxia , dyspnea 
and diarrhea. 
Cattle exhibited anorexia, muscle tremors, incoordination, weakness and slower 
rumen motility when given feed containing lasalocid or monensin (Galitzer, 1986). 
Severely affected animals show signs of toxicity within 24 hours of intoxication. 
Diarrhea and ataxia are also observed in cattle exposed to very high levels of monensin. 
Death may occur without signs (Novilla, 1992). Newborn calves dosed with 5 mg/kg of 
lasalocid showed respiratory distress and incoordination (Benson, 1998). In addition, the 
calves developed muscle weakness, ataxia and increased heart rate. In gross pathologic 
examination, pulmonary edema and congestion and ecchymotic hemorrhage in gluteal 
muscle were observed. Microscopic lesions included myocardial necrosis, coagulative 
necrosis and hemorrhage in skeletal muscle and swelling of vascular endothelial cells of 
brain. Slight changes in serum and blood chemistry were also seen with increased AST 
and CK levels (Benson, 1998). 
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Horses are considered more sensitive to ionophore toxicity than cattle. Oral LD50 
of monensin is reported to be 2-3 mg/kg in horses (Galitzer, 1995). Lasalocid appears to 
be less toxic than monensin in horses since the estimated LD50 of lasalocid is 21.5 mg/kg. 
Similar to cattle, clinical signs include anorexia, ataxia, paresis, reduced activity and 
death (Hanson, 1981 ). Cardiac muscle is especially sensitive to Monensin and Lasalocid 
toxicity in horses. Tachycardia and cardiac muscle damage are a result of this sensitivity. 
In terms of cardiac toxicity, salinomycin is less toxic than monensin and lasalocid 
(Oehme and Pickrell, 1999) . 
. In avian species, toxicity cases were reported in hens and turkeys. Hens and 
turkeys developed dyspnea, wing dropping, reduced egg production, reluctance to move 
and gait abnormalities due to ionophore toxicosis (Halvorson, 1982). In addition, reduced 
body weight gain and growth rate were observed in chickens fed ration containing 
monensin (Wagner, 1983). Small pale spleen, congestion of liver and lungs were 
observed in intoxicated hens. Cardiac and skeletal muscle damage were also observed in 
affected birds. Birds show myodegeneration in skeletal muscle with hyalinization and 
subepicardial hemorrhage, and congestion in the ventricle walls (Halvorson, 1982; 
Wagner, 1983). 
Mechanism of Toxicity of lonophores 
The normal ionic gradient of the cell is maintained and tightly controlled by 
specialized transport complexes found in cell membranes. Examples of these complexes 
are Na+-K+-ATPase, Ca++-Mg++- ATPase, and Na+-ca++ counter transport systems. If the 
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cell membrane becomes permeable to ions which are normally controlled by these 
systems through ionophore mediated transport, the cells lose their ability to control and 
maintain physiologic ion gradients. Most of toxic effects of ionophores are thought to be 
mediated by disrupting the normal ionic gradients of cells (Elsasser, 1984). Alterations in 
cellular Ca++ concentration by lasalocid have been associated with disturbances in normal 
physiological function of the cardiac tissue due to dynamic regulation of cardiac muscle 
contractility by Ca++. Ionophore cytotoxicity is thought to involve an influx of Na+ and 
Ca++ ions with simultaneous efflux of K+ ions leading to excess Ca++ overload within 
mitochondria, mitochondrial damage, lack of cellular energy and ultimately muscle 
necrosis (Novilla, 1992). Another mechanism of Ca++-mediated cell death occurs via 
apoptosis. It is thought that ionophores lead to apoptosis via calcium-activated 
endonucleases (Ojcius, 1991). Another mechanism leading to cell death is reported to be 
associated with activation of influx of Ca++ through NMDA receptor leading to activation 
of phospholipase A2 and release of arachidonic acid (Safran et al., 1996). Toxic effects 
on cardiac cells were also observed with monensin which typically affects Na+ transport 
across the membranes. The basis for the cardiac effect of monensin is that movement of 
Na+ ions inside the cell triggers Na+/Ca++ exchange system leading to influx of Ca++ 
(Mollenhauer, 1990). 
The cardiac toxicity of some ionophores by this manner was studied in neonatal 
rat cardiac myocyte. Monensin induced cardiac myocyte cytotoxicity at concentrations 2'.: 
10 mM in vitro. The effect caused by monensin on cardiac myocyte included "blebbing" 
of cell membranes and cellular swelling (Sihier and DuBourdieu, 1992). The elevated 
levels of Ca++ may affect numerous other cellular processes. The cellular processes 
9 
activated by Ca++ include mostly intracellular signaling pathways and inference with 
important cellular enzyme systems including auto-oxidation of macromolecules, 
activation of phospholipase A2, endonucleases and proteases with an end result of 
cytotoxicity (Tymianski and Tator, 1996). 
Another effect of ionophores is seen on energy metabolism. Alteration of the 
cellular ionic gradient by ionophores can deplete intracellular ATP levels. This effect is 
much more detrimental in prokaryotic cells and accounts for its somewhat selective 
action. For example, monensin causes an influx of Na+ ions leading to increased 
intracellular Na+ concentration. The cell reacts by expending ATP to maintain normal 
Na+balance inside the cell. Subsequently, cells cannot meet the demand for ATP and lyse 
(Bergen, 1984). The reason for the selective action of ionophores on prokaryotes is based 
on differences on mode of energy usage and ability for osmoregulation. Coccidia are 
intracellular parasites that rely on the host cell for energy. Ionophores stimulate coccidia 
sporozoite's Na+-K+-ATPase as a consequence of ionic disturbance. However, rate of ion 
influx exceeds the capability ofNa+-K+-ATPase pump to remove excess Na+ ion because 
of depletion of energy sources. Increased intracellular Na+ is followed by an influx of Cl 
to maintain electroneutrality. This in turn brings water from exterior causing swelling of 
the parasite. Since the coccidia have no osmoregulatory organelles, coccidia swell and 
burst (Smith and Galloway, 1983). 
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Effects of lonophore Toxicity on Nervous System 
Alterations of nervous and muscle tissues were observed in ionophore induced 
toxicity. Lasalocid caused membrane depolarization in rat muscle fibre membranes and 
induced spontaneous release of acetylcholine in phrenic nerve-diagram muscle 
preparation (Jansson, 1976). Lasalocid also increased acetylcholine release from rat brain 
in vitro by an unknown mechanism (Richter, 1977). 
It has been reported that lasalocid, monensin, and ionomycin stimulate release of 
catecholamines from rat pheochromocytoma and this effect may be dependent on 
increasing intracellular Ca++ (Perlman, et al., 1980). Furthermore, lasalocid and 
ionophore A 23187 caused inhibition of fast axonal transport and decreased axonal 
microtubules with a concomitant increase in total calcium content of the nerve (Kanje, et 
al., 1981 ). One study showed that lasalocid caused selective degeneration of nerve cells 
in vitro by a mechanism dependent on increased Ca++ influx. This effect of lasalocid was 
blocked by the NMDA receptor blocker MK-801, suggesting possible involvement of 
excitatory amino acid in the neurotoxicity ofLasalocid (Safran, et al., 1996). 
Alterations in nerve tissues and related clinical signs were reported in broiler 
chickens fed with Lasalocid. For example, lasalocid caused a dose dependent 
neurotoxicity in broiler chickens at doses greater than 11.25 mg/kg. The clinical 
manifestation of neurotoxicity resulted in ataxia. Nerve tissues from affected birds 
showed a number changes in histopathologic examinations. These included myelin 
disruption, degeneration and vacuole formation in myelin (Gregory et al., 1995; Roder, 
1996). Salinomycin and monensin toxicity was reported in turkey breeders. The clinical 
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condition in affected birds included paralysis of legs leading to gait disturbances and 
abnormal positioning of head (Halvorson, 1982). Contamination of cat food with 
salinomycin resulted in an outbreak of salinomycin neurotoxicity .in cats. Toxicated cats 
developed paresis and paralysis of hindlimbs and lameness. Postmortem examination 
indicated a distal polyneuropathy including sensory and motor neurons. Although both 
central and peripheral nerves were found to be affected, peripheral nerve injury was more 
severe in affected cats. Lesions were localized in axons, myelin sheath, and Schwann 
cells. These included destruction of myelin sheath with formation of digestion chambers, 
collapsed axonal sheath filled with foamy macrophages, and swollen Schwarm cells (Van 
der Linde-Sipman, 1999). Rodent species can also be affected by ionophore 
neurotoxicity. Gad et al (1985) reported that some ionophores including lasalocid cause 
neurobehavioral signs in mice and rats. Rats dosed with oral ionophores developed 
tremors, tonic-clonic convulsions and aggressive behaviors. 
These reports clearly indicate that one of the toxic effects of ionophores is related 
to nervous tissues and these effects are capable of inducing clinical, pathological changes 
in nerves which can be called ionophore induced neurotoxicity. Although the cellular 
effect of ionophores is attributable to their ability to facilitate ion movements across cell 
membranes, the mechanism in neurotoxicity is not extensively studied. 
One way to study neurotoxicants is to use chemical agents which have the ability 
to modulate neurotoxicity. Phenylmethylsulfonyl fluoride (PMSF), a serine protease 
inhibitor, is such an agent which has been used for decades in the mechanistic evaluation 
of organophosphate induced delayed neuropathy (OPIDN). Neuropathies of different 
etiology can be promoted by PMSF (Moretto, 1993). Xu et al., (1999) reported that 
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PMSF significantly increased ataxia induced by p-bromophenylacetylurea in F-344 rats. 
Phenylmethylsulfonyl fluoride increased the concentrations of p-bromophenylacetylurea 
and its toxic metabolite suggesting that PMSF alters the toxickinetics of p-
bromophenylacetylurea, leading to increased concentration of the toxicant in tissues. 
2,5- Hexanedione neuropathy was also reported to be promoted by PMSF. 
Mechanism of 2,5-Hexanedione toxicity (crosslinking of neurofilaments) differs from 
OPIDN (Moretto, 1992). 
These results show that ionophore induced neurotoxicity can be modulated by 
PMSF. However, the role of PMSF and some other modulators in OPIDN first need to be 
reviewed to gain insight into the mechanism of OPIDN. Therefore the rest of the 
discussion will be on OPIDN. 
Overview of Organophosphate Induced Delayed Neurotoxicity (OPIDN) 
Many organophosphorus (OP) toxicants irreversibly inhibit the enzyme 
acetylcholinesterase. A cetylcholinesterase normally degrades a cetylcholine into choline 
and acetic acid at cholinergic synapses. Organophosphate poisoning thus causes the 
accumulation of acetylcholine, allowing it to react with nicotinic and muscarinic 
receptors on the postsynaptic cells. The resultant effect is manifested by excess 
stimulation of cholinergic nerves with related symptoms such as excessive secretions and 
convulsions (Hayes and Laws, 1991). The cholinergic effect of OP is a well-known and 
documented aspect of OP poisoning. However, neuropathy is another possible 
consequence of OP exposure. A single dose of some OPs is enough to cause irreversible 
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neuropathy 2-3 weeks after exposure (Johnson, 1990). This effect of OP poisoning is 
referred to organophosphate induced delayed neuropathy (OPIDN). Earlier in the 
elucidation of mechanism of the OPIDN, it was thought that brain acetylcholinesterase 
and butyrylcholinesterases might be involved in the mechanism of OPIDN. Later it was 
found that organophosphate induced delayed neuropathy has no relation to the inhibition 
of acetylcholinesterase (Carrington, 1989). The neurotoxic effect was then found to be 
associated with phosphorylation of a brain protein called neuropathy target esterase 
(NTE) by certain OPs (Johnson, 1969, 1974). Interestingly, while some OPs are able to 
inhibit NTE and cause OPIDN, some OPs; carbamates and phenylmethylsulfonyl fluoride 
have the ability to inhibit the enzyme, but they are unable to produce OPIDN (Johnson, 
1970). Furthermore, studies showed that the neurotoxic effect of neuropathic OPs can be 
prevented or potentiated with the administration of these non-neuropathic NTE inhibitors 
in a sequence-dependent manner (Pope and Padilla, 1990; Massicotte, 1999). To gain 
insight into the potentiation, protection and other aspects of OPIDN by certain chemicals, 
it is necessary to review the literature of OPs. 
Chemistry of Organophosphorus Compounds 
Although o rganophosphorus compounds show great diversity in details o ft heir 
chemical structure, they have common backbone. Organophosphorus are aliphatic 
carbon, cylic, or heterocylic phosphodiesters (Osweiler, 1996; Hayes and Laws, 





Figure 2. Chemical Structure of organophosphorus compounds. 
Pentavalent phosphorus posses double bond with either a sulfur or an oxygen (P=O is 
capable of inhibiting esterases). "R" groups can vary and bind to the phosphorus either 
directly ( example of this is phosphinates ), via an oxygen ( example of this phosphates) or 
via nitrogen (phosphoroamidates) (Lotti, 1992). 
Interactions of Organophosphorus Compounds with Target Esterases 
Esterases can be divided into two groups which are A esterases and B esterases. A 
esterases detoxify OPs while B esterases are inhibited by OPs and the latter comprises 
target esterases (Example: Acetylcholinesterase) in the body. The active site of the 
esterase, serine hydroxyl group, is phosphorylated, and the active site is then slowly 
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reactivated by hydrolysis. A subsequent reaction might take place after phosphorylation 
called aging, however which leaves a negatively charged phosphoryl residue leading to 
irreversible inhibition of the enzyme (Lotti, 1992). 
Role of Neuropathy Target Esterase Enzyme (NTE) in Organophosphorus Induced 
Delayed N europathy 
After the discovery ofNTE, extensive research has focused on the role ofNTE in 
the initiation of OPIDN. Involvement of NTE in OPIDN was first discovered with the use 
of non-neuropathic NTE inhibitors. Some chemicals such as PMSF (serine protease 
inhibitor) and carbamates showed strong inhibitory effect on NTE in vivo, but without 
producing neuropathy. However, when animals were co-exposed to these chemicals were 
applied with neuropathic OPs, it was noted that neuropathy induced by OPs can be either 
protected or potentiated depending on the sequence of application (Pope, 1993). 
Johnson (1970) showed that certain non-neuropathic NTE inhibitors (PMSF) given prior 
to neuropathic OPs have protective effect from OPIDN in spite of its extensive inhibitory 
effect on NTE. Interestingly, given after a neuropathic OP, PMSF promotes the 
neuropathy (Pope and Padilla, 1990). It was postulated that initiation occurs by a two step 
process. The first step includes phosphorylation of active site of NTE, and the second 
step includes "aging" leading to alteration in membrane micro environment and 
disturbance of homeostasis causing degeneration of long axons. In the protection it was 
postulated that the second step does not occur because PMSF and carbamates are not 
capable of aging. Secondly, as a result of occupation of NTE's active site by these 
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compounds the enzyme is protected from neuropathic agent (Johnson, 1974; Pope 1993). 
Young chickens are resistant to OPIDN (Johnson and Barnes, 1970), but PMSF can 
increase sensitivity to OPIDN (Johnson and Lauwerys, 1969; Pope and Padilla 1990; 
Pope et al., 1993). It was postulated that NTE may not be involved in promotion of 
OPIDN. Higher doses of neurotoxic OPs show no effect in young chickens despite the 
inhibition of NTE which is enough to induce OPIDN in adult chickens. However, young 
chicks become sensitive with PMSF following the neuropathic agent. These studies 
suggested that NTE may not be the target for promotion (Pope et al, 1992; Harp et al, 
1997). 
Neuropathy Target Esterase 
Neuropathy target esterase is a protein which is found in many tissues. The 
highest concentration of the enzyme was reported to be in the brain, whereas most of the 
esterase activity is membrane bound mainly in the endoplasmic reticulum and plasma 
membrane. Neuropathy target esterase can also be found in different tissues other than 
nerve tissues. For example, NTE was found in spleen and lymphocytes in higher 
concentrations (Carrignton, 1989). Despite extensive research, little is known about the 
physiological role of NTE. Even with long term inhibition by phosphinates and sulfonyl 
halides (PMSF) NTE inhibition did not cause OPIDN. Therefore, no correlation has been 
found between the NTE inhibition and well-being of a neuron (Lotti and Moretto, 1993). 
Primary sequence of human NTE and mouse NTE has high similarity to swiss cheese 
protein (SWS) in nerves of Drosophila melonagaster. Flies without this protein are 
affected by glial hyperwrapping and neurodegeneration. A recent article showed for the 
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first time NTE is essential for embryonic development in mice. Genetic ablation ofNTE 
in mice resulted in hyperactivity, and it was suggested that NTE may play a role in motor 
activity in mammals (Winrow et al., 2003). 
Clinical and Histopathological Presentation of OPIDN 
Clinical manifestation of OPIDN is characterized by a delay period which is seen 
between 8 to 14 days after dosing. The hen has been the animal model in studies of 
OPIDN to characterize the clinical expression of OPIDN in animal species. Hens given a 
single dose of 1 mg/kg diisopropyl flurophosphate start to show first sign of ataxia after 8 
days following dosing with slight incoordination and leg weakness. Then ataxia 
progresses with time, and complete ataxia and marked paralysis of the legs develop by 
day 13 (Sprague and Bickford, 1981). The delayed neurotoxic effect of some OP 
compounds can be altered by the time dependent administration of PMSF. It has been 
shown that PMSF intensifies the ataxia when given following a neuropathic OP dosing. 
In addition, age is another factor in the clinical expression of OPIDN in response to OP 
treatment. Young chicks are known to be resistant to OPIDN. For instance, while 5 
week-old chicks appeared normal in response to OP treatment, chickens receiving same 
treatment and dose of OP at 8 weeks age developed ataxia. Interestingly, young chicks 
(for example at 5 weeks of age) become sensitive to the same OP treatment with PMSF 
post treatment (Pope et al., 1992; Harp et al., 1997). 
Lesions in affected animals are distributed in central and peripheral nerves. 
Within the CNS, the spinal cord is mainly affected with axonal degeneration. Axons 
appear fragmented and swollen and myelin around the axon is lost. In peripheral nerves, 
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large and long axons are more susceptible to the damage induced by OPIDN. Changes in 
peripheral nerves include focal nerve fiber varicosities and paranodal demyelination in 
the distal part of the nerves. The changes in central and peripheral nerves are defined as a 
central-peripheral distal sensory-motor a xonopathy since distal parts of 1 ong axons a re 
mainly affected (Soliman, 1983; Lotti, 1992). 
Statement of Dissertation and Hypotheses 
The role of PMSF in the modulation of some neuropathies has been reported in 
several studies. While PMSF has been utilized mainly in the elucidation of mechanism of 
the OPIDN, several researchers suggested that PMSF can also modulate neuropathies 
induced by some other neurotoxicants. The neurotoxic effect of lasalocid is believed to be 
associated with the unique action of this antibiotic on alteration of ionic homeostasis of 
cells by facilitating ion movement across membranes. In contrast to the mechanism of 
lasalocid toxicity, OPs toxicity is attributed to inhibition of NTE. While the initiation of 
OPIDN requires inhibition of NTE, current mechanistic explanations for OPIDN still lack 
conclusive evidence, and little is known regarding the modulatory effect of PMSF. The 
purpose of the first part of this study was to evaluate and characterize lasalocid induced 
neuropathy in 3 and 6 week-old chickens by oral gavage of 1 asalocid with or without 
PMSF. The neurotoxicity was characterized using clinical scoring system, light and 
electron microscopy and electrophysiology. The hypothesis for this phase of the study 
was that lasalocid induces neuropathy in broiler chickens, and PMSF potentiates lasalocid 
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induced neuropathy. Several reports demonstrated that PMSF can modulate different 
types of neuropathies besides OPIDN. It is believed that potentiation of OPIDN byPMSF 
is not associated with the inhibition of NTE. Therefore, it can be expected that 
neuropathies of different origin may be potentiated by PMSF. Results from potentiation 
studies of several different neuropathic agents with PMSF showed that 2-5-hexanedione 
was promoted by PMSF in hens (Moretto et al., 1992). Furthermore, it was shown that p-
Bromophenylacetylurea neurotoxicity was also potentiated by PMSF (Xu,, et al., 1999). 
There is no plausible explanation for exact mechanism of potentiation of different 
neuropathies by PMSF. However, it can be speculated that PMSF can modulate LA-
neurotoxicity by interfering with Ca++ homeostasis. It was reported that TOCP treated 
hens showed decreased Ca++ in scitic nerve homogenates (Lutrell, et al., 1993). 
Furthermore, it was shown that during the protection of OPIDN by PMSF, PMSF 
prevented reduction of serum Ca++ level which was increased during PMSF potentiation 
of leptophos (Piao, et al., 2003). The toxicity of LA is linked to increased cellular Ca++ 
overload through facilitation of Ca++ influx. A recent study also demonstrated that NTE 
may have lysophospho lipase activity (LysoPLA) which leads to accumulation of 
lysolecithin. Lysolecithin is a membrane protein whose accumulation has been associated 
with myelin degredation (Quisdat, 2003). Since PMSF is an NTE inhibitor, it can inhibit 
LysoPLA and can be involved in the potentiation in this manner. Therefore, an 
interaction between PMSF and LA could be possible in this manner. The second part of 
the thesis deals with developing a rat model of lasalocid neuropathy and examines the 
effect of dietary salt on lasalocid induced neuropathy. Dietary levels of K+ and some 
other ions might influence ionophore toxicity (Halvorson, 1982). In poultry industry, it is 
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known that incidence of LA toxicosis with increased water salinity is higher during hot 
summer period. With the combination of environmental stress factors, increased 
temperature and water deprivation may play a role in a higher rate of LA neurotoxicity 
and cardiotoxicity (Gregory et al., 1995). The hypothesis for this phase of the study was 
that lasalocid neurotoxicity is increased by the addition of salt to the diet. To determine 
the dose given by the oral route that causes the neurotoxic syndrome in rats by LA, a 
dose-response study was performed. This helps to characterize and describe the 
neurotoxic syndrome and develop a rodent model for LA induced neuropathy. The final 
phase of the second part examined the effect of PMSF posttreatment on lasalocid 
neuropathy in rats. Although promotion of 2,5-hexanedione by PMSF was shown in hens, 
same effect was not achieved in rats. Similar resistance to potentiation of acrylamide 
neuropathy by PMSF was also observed in rats (Moretto and Lotti, 1993). 
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MODULATION OF LASALOCID INDUCED NEUROPATHY BY 
PHENYL METHYL SULFONYL FLUORIDE IN 3 AND 6 WEEK-OLD 
BROILER CHICKENS 
Abstract 
Phenyl Methyl Sulfonyl fluoride (PMSF) can potentiate the neuropathy caused by 
some organophosphorus (OP) and other types of neurotoxicants ( e.g., p-
bromophenylacetyl urea). Lasalocid is a feed additive used in chickens that is known to 
cause a peripheral neuropathy. We investigated the ability of PMSF to exacerbate the 
clinical signs and morphological lesions of lasalocid-induced neuropathy in broiler 
chickens. Ultrastructural changes, electrophysiologic characteristics before and after 
lasalocid exposure in different age groups o fbroiler chickens, and neurotoxic esterase 
activity (NTE, an enzyme whose inhibition is highly correlated with induction ofOP-
induced neuropathy) were evaluated. LA (30 mg/kg t.i.d. for 2 days) was given to two 
different age groups (3 and 6 week-old of chickens), with or without a single dose of 
PMSF (90 mg/kg, sc) before or after the last LA treatment. All birds were observed daily 
for .8 days for clinical signs of neuropathy and tissues (brain, spinal cord and sciatic 
nerve) were removed for histopathologic examination at the end of each study. PMSF 
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increased ataxia induced by LA in 3 and 6 weeks of age broiler chickens. While LA did 
not affect NTE enzyme activity, PMSF decreased NTE activity of spinal cord, brain and 
sciatic nerve in both age groups. LA markedly reduced Motor Nerve Conduction 
Velocity (MNCV) in the sciatic nerve, but PMSF had no effect alone or in combination 
with LA. Histopathologically, LA caused lesions only in sciatic nerve. Spinal cord 
degeneration was noted in birds treated with both LA and PMSF. However, PMSF alone 
had no effect. These results suggest that PMSF can potentiate the neurotoxicity induced 
by LA. The mechanism for this modulation requires further investigation. 
Introduction 
Neuropathy is a term which describes pathological changes in motor, sensory and 
autonomic neurons as evidenced by derangement in both structure and function. 
Depending on the nature of the insult, neuropathies can be localized to axon, myelin or to 
the whole neuron body (Riaz and Tomlinson, 1996). Many toxicants including some 
organophosphates (OP) and Lasalocid (LA), a carboxylic ionophore, are capable of 
producing neuropathy (Soliman, 1983; Roder, 1996). 
OPs are known to produce a delayed neuropathy in man and domestic animals. 
Toxic signs induce flaccid paralysis of lower and upper limbs and changes in neurons 
defined as a central-peripheral distal sensory-motor axonopathy. Although the 
mechanism is not clearly understood, it is believed that inhibition of Neuropathy Target 
Esterase (NTE) initiates organophosphate induced delayed neuropathy (OPIDN) (Lotti, 
1992). It is proposed that induction of OPIDN occurs by a two step process. NTE is· 
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phosphorylated, and subsequently the OP compound undergoes "aging" leading to 
alteration in membrane micro environment and disturbance of homeostasis (Pope, et al. 
1993). Several studies indicated that NTE plays a role in lipid metabolism and signaling 
pathway and NTE was shown to be an integral membrane protein (Van Tienhoven, M., et 
al., 2002; Atkins, J., and Glynn, P., 2000). A recent report suggests that NTE may be 
involved in control of motor activity (Winrow, et al., 2003). NTE is an enzyme whose 
exact physiological function is still to be determined, nevertheless inhibition of NTE by 
OPs has been related to their ability to induce OPIDN (Johnson, 1988).While NTE 
inhibition appears to initiate O PIDN, other chemicals such as c arbamates, p hoshinates 
and sulfonates also have NTE inhibitory effect, but they are unable to produce OPIDN. 
Phenyl methyl sulfonyl floride (PMSF) is one such agent. Studies in chickens 
have shown that when given prior to a neuropathic OP, PMSF can prevent OPIDN. In 
contrast if PMSF is given after OP administration, delayed neuropathy is exacerbated. 
Some studies also indicate that PMSF can potentiate p-Bromophenylacetylurea induced 
neuropathy in rats (Xu, et al., 1999) and delay the recovery from nerve crush (Moretto, et 
al., 1993). Young chickens are resistant to OPIDN (Johnson and Barnes, 1970), but 
PMSF can increase sensitivity in young animals(Harp et al, 1996; Pope et al., 1993). 
Lasalocid is capable of complexing with mono and divalent cations and forming a 
lipid soluble structure in membranes, thus allowing passive diffusion of cations across 
cellular membranes. Ionophores are useful as feed additives to improve feed efficiency 
and as coccidiostat in the poultry. lonophores have caused a number of toxic effects in 
animals including cardiotoxicity, muscle damage, and hepatotoxicity (Galitzer and 
Oehme, 1984). Furthermore, in vitro incubation of Ca ++ with LA resulted in severe 
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intramyelinic splitting suggesting a role for Ca++ in the mechanism of LA induced 
peripheral neuropathy (Roder, 1996). We investigated whether PMSF may alter LA-
induced neurotoxicity. 
Materials 
Lasalocid A Na Salt (Purity ~ 97 %) and PMSF were purchased from Sigma 
Chemical Company (St. Louis, MO). Lasalocid was placed into gelatin capsules (Lilly 
Company®). Phenyl valerate and Phenyl saligenin phosphate (PSP) was purchased from 
Oryza Laboratories, Inc. (Chelmsford, MA). Paraoxon (diethyl 4-nitrophenyl phosphate) 
was purchased from Chem Service (West Chester, PA). Mipafox, Trizma® base, EDTA, 
SDS, 4-aminoantipyrine, and potassium ferri cyanide and dimethyl sulfoxide (DMSO) 
and glycerol formal were purchased from Sigma Chemical Company (St. Louis, MO). 
Animals and Treatments 
One day old broiler chickens (Cobb-Cross) were obtained from a commercial 
source. Chicks were housed in floor pens and maintained at 30 °C under a 23: 1hr light: 
dark illumination cycle. Feed and water were provided ad libitum. At three and six weeks 
of age, the chickens were randomly divided into eight treatment groups containing 11 
birds each. Controls were treated with empty gelatin capsules. Chickens were treated with 
LA (30 mg/kg t.i.d for 2 days) with or without PMSF (90 mg/kg, sc) in glycerol formal 
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four hours before initiating LA treatments, or four hours after the last LA treatment. 
Table 1 shows the groups with their respective treatments in 3 and 6 week-old chickens. 
Table I. Treatment groups in 3 and 6 week-old chickens 
Group n Age (week) Treatment 
PMSF Pre-treatment 
1 11, 11 3, 6 GF (0.Sml/kg, sc) + LA (0 mg/kg) t.i.d. 2 days 
2 11, 11 3, 6 PMSF (90 mg/kg, sc) + LA (0 mg/kg) t.i.d 2 days 
3 11, 11 3, 6 GF(O.Sml/kg, sc) + LA (30 mg/kg) t.i.d. 2 days 
4 11, 11 3,6 PMSF (90 mg/kg, sc) + LA (30 mg/kg) t.i.d 2 days 
PMSF Post-treatment 
5 11, 11 3, 6 LA (0 mg/kg) t.i.d. 2 days + GF (0.Sml/kg, sc) 
6 11, 11 3, 6 LA (0 mg/kg) t.i.d 2 days + PMSF (90 mg/kg, sc) 
7 11, 11 3, 6 LA (30 mg/kg) t.i.d. 2 days + GF (O.Sml/kg, sc) 
8 11, 11 3, 6 LA (30 mg/kg) t.i.d 2 days + PMSF (90 mg/kg, sc) 
Twenty four hours after the last treatment, three birds were randomly selected from each 
group for NTE determination and killed by CO2 asphyxiation. For. motor nerve 
conduction velocity (MNCV) studies, three birds from each treatment group were 
randomly selected two days after the onset of clinical ataxia. The remaining chickens 
were observed for 8 days and daily ataxia scores were assigned to each bird. At day 8, 
three birds from each group were randomly chosen for histopathologic examination. 
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Clinical Signs and Observations 
All chickens were observed "blind" daily throughout dosing and for 8 days for 
clinical signs of ataxia. Initially, birds were observed without disturbing for behavioral 
changes, and then the birds were forced to walk for several minutes to determine the 
degree of ataxia and to identify if ataxia worsened after exercise. Ataxia scores were 
given according to clinical ataxia scoring system (Table 2). 
Table II. Clinical Ataxia Scoring System 
Score Definition 
0 Normal Birds 
1, 1+ Slight Ataxia after exercise 
2,2+ Slight Ataxia, Ataxia worsens after exercise 
3,3+ Ataxic birds 
4,4+ Non-ambulatory, alert 
5,5+ Non-ambulatory, not alert, depressed 
N eurotoxic Esterase Assay 
Neurotoxic esterase activity of nerve tissues can be measured by a differential 
assay based on relative sensitivity to inhibition of by mipafox and insensitivity to 
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inhibition by paraoxon. The hen brain shows at least 4 ·different esterase activity other 
than NTE which hydrolyse phenyl valerate. Neurotoxic esterase can be measured by the 
preincubation of two samples with paraoxon or paraoxon plus mipafox before the 
addition of substrate. The difference between the two activities gives NTE activity 
(Johnson, 1977). Brain, spinal cord and sciatic nerve of randomly selected birds from 
each treatment group were dissected and stored at -70 °C until the day of assay. NTE 
activity was measured by the method of Johnson (1977), as modified by Solimon et al 
(1982), with slight changes in the incubation time. 
Briefly, tissues were homogenized on ice in 9 volumes of 50 mM Tris (hydroxymethyl) 
amino methane buffer, pH 8.0 containing 0.2 mM EDTA (Tris-EDTA). After 
homogenization, tissues were centrifuged at 9000xg for 15 minutes. Supematants of 
brain (25 µ1), spinal cord (25 µl), and sciatic nerve (40 µ1) were added to paired tubes (all 
samples were analyzed in duplicate). Subsequently, paraoxon (50 µ1, 0.6 mM) was added 
to all tubes with or without mipafox (50 µ1, 0.75 mM). After 20 minutes ofpreincubation 
in a 3 7 °C water bath, 5 µ1 of a 25 mg/ml phenyl valerate in water was added to the 
reaction tubes. Samples of brain, spinal cord and sciatic nerve were incubated in a 37 ° C 
water bath for 10, 20 and 60 minutes, respectively. The reaction was stopped with 0.5 ml 
of 50 mM Tris/EDTA containing 1 % sodium dodecyl sulfate and 0.025 % 4-
aminoantipyrine. Potassium ferricyanate (0.4 %, 0.25 ml) in water was added to each 
reaction tube to develop a stable color. After waiting at least 5 minutes, absorbance at 
510 nm was recorded. Absorbance values were used to calculate NTE activity as the 
difference in hydrolysis of phenyl valerate in the absence and presence of mipafox. The 
extinction coefficient for a µM solution is 0.0139, and this was used to convert to mole 
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equivalents phenyl valerate hydrolyzed. NTE activity was reported as nmol 
phenol/minute.mg tissue. 
Motor Nerve Conduction Velocity Studies· 
Motor nerve conduction velocity (MNCV) was evaluated in three birds from each 
treatment group in 3 and 6 week-old chickens. Chickens were anesthetized (i.m.) with the 
combination of xylazine (5 mg/kg) and ketamine (15 mg/kg). Birds were positioned in 
lateral r ecumbency, and recordings were taken from the 1 e:ft sciatic nerve. Stimulating 
and recording electrodes were placed caudal to the greater trochanter (gluteal fold) and 
disto-lateral tarsometotarsal joint (popliteal fossa), respectively. The nerve was 
stimulated with supramaximal stimuli of lms duration at a rate of 1/second using 
Biosound Genesis 3000-AP. 
Histopathologic Examinations 
Light Microscopy: Three birds from each group were randomly selected for 
necropsy and subsequent histopathologic and ultrastructural studies. The chickens were 
euthanized in a CO2 chamber. The Sciatic and tibial nerves were dissected and fixed in 
2.5 % buffered glutaraldehyde. The entire spinal cord was dissected by complete removal 
of the dorsal and lateral portions of the vertebrae and fixed in 2.5 % glutaraldehyde. The 
brain and sections of heart and skeletal muscle were removed and placed in fixative. 
Sections for histopathologic examination were embedded in paraffin, cut 4-6 µm thick 
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and stained with hematoxylin and eosin (H&E). Selected sections of sciatic nerves and 
spinal cord were also stained with Severe-Munger and counterstained with L uxol Fast 
Blue. All sections of tissue were examined by light microscopy and lesions were scored 
"blind". Lesions in the sciatic nerve and spinal cord were graded according to the 
following scale: 
Nerve Lesions: 
0 - No lesions 
1 - Swollen axons, foamy vacuolation ofmyelin 
2 - Small distinct random vacuoles (Voids) in myelin 
3 - Distinct vacuoles in myelin with atrophy and/or fragmentation of axons 
4 - Large distinct myelin vacuoles (Voids), digestion chambers (axon-myelin debris), or 
loss of axons. 
Spinal Cord Lesions: 
0 - No lesions 
1 - Small number of degenerating axons 
2 - Moderate number of degenerating axons 
3 - Numerous degenerating axons 
Electron Microscopy: Sciatic nerves from affected birds were fixed in a 
glutaraldehyde/formalin mixture. Nerve pieces were washed with 0.1 M cacodylate 
buffer three times for 20 minutes. Gross longitudinal and transverse slices of the nerve 
segments were cut by razor blade. The tissues were post-fixed in 1 % cacodylate buffered 
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osmium for two hours then washed three times in 0.1 M cacodylate buffer. Following 
post-fixation, the tissues were dehydrated through graded ethanol series (50, 70, 90, 95, 
100) and washed three times with propylene oxide for 20 minutes. The tissues were 
placed into 1:1 propylene oxide/hard polybed and polymerized a 60 ° C for 48 hours. 
Blocks of the nerve pieces were thick-sectioned and areas of interest were subsequently 
processed for thin sectioning. Thin sections of samples were examined using a JEOL 100 
CX scanning electron microscope at 80 KV. 
Data Analysis: 
Analysis of variance procedures were utilized to compare treatment groups in 3 
and 6 week-old chickens and for each experiment. For ataxia scores, since data is not 
continuous, group data are presented as medians±interquartile range (interquartile range: 
75th percentile minus 25th percentile of data). For all other endpoints, group data are 
presented as means. For all analyses, PROC MIXED in PC SAS Version 8.2 was used to 
perform the analyses of variance, and a Least Significant Difference multiple comparison 
test was used to assess the significance of individual group comparisons. Significance 
level of0.05 was used for comparisons of treatments. 
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Results 
Clinical Signs and Ataxia 
Figure 5 shows the effects of PMSF pretreatment on LA-induced ataxia in 3 
week-old chickens. No signs of ataxia were observed in control or PMSF-treated birds. 
LA-treated birds or chickens treated with PMSF+LA exhibited varying degrees of ataxia. 
Response ranged from no ataxia with clinically normal appearance to severe ataxia and 
death. While control · birds and PMSF treated birds were alert and clinically normal, 
affected b irds w ere reluctant to move and appeared to b e s luggish. When the affected 
birds were disturbed or forced to walk, they were slow and walked with frequent resting. 
Onset of clinical ataxia was observed as early as 16 hours after the first exposure in LA 
or LA+PMSF treated birds (Groups 3 and 4). 
Figure 6 shows effects of PMSF posttreatment on LA-induced ataxia in 3 week-
old chickens. Clinically, control and PMSF only group did not show any abnormality. 
However, groups treated with LA and LA+PMSF (Groups 7 and 8) appeared ataxic. 
Ataxia was most severe on the 3rd day of post LA application in these groups. 
Figure 7 shows effects of PMSF pretreatment on LA-induced ataxia in 6 week-old 
chickens. No signs of ataxia were observed in control and PMSF only group. Both LA 
and PMSF+LA groups responded with ataxia. However, based on daily median ataxia 
scores, PMSF+LA caused higher ataxia throughout the observation period (day 1-7) 
compared to the LA only group. 
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Figure 8 shows effects of PMSF post treatment on LA-induced ataxia in 6 week-
old chickens. Similarly, control and PMSF only group appeared normal. However, 
































Figure 3. Effects of PMSF pretreatment on LA-induced ataxia in 3 and 6 week-old 
chickens as cumulative Median Ataxia Scores ± interquartile ranges. Asterisk indicates 
significant effect of PMSF on LA ataxia, at p < 0.05. 
GF+LA(O) (Group 1): Control 
PMSF+LA(O) (Group 2): Pretreatment with PMSF (90 mg/kg, s.c.) and LA (0 mg/kg) 
GF+LA(30) (Group 3): Glycerol formal and LA (30 mg/kg, t.i.d. for 2 days) 









































Figure 4. Effects of PMSF posttreatment on LA-induced ataxia in 3 and 6 week-old 
chickens as cumulative Median Ataxia Scores ± interquartile ranges. 
LA(O)+GF (Group 5): Control, 
LA(O)+ PMSF (Group 6): LA (0 mg/kg) and post treatment with PMSF (90 mg/kg, s.c.), 
LA(30)+GF (Group 7): LA (30 mg/kg, t.i.d. for 2 days) and Glycerol formal, 
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Days After Treatment 
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Figure 5. Effects of PMSF pretreatment on LA-induced ataxia in 3 week-old chickens. 
GF+LA(O) (Group 1 ): Control 
PMSF+LA(O) (Group 2): Pretreatment with PMSF (90 mg/kg, s.c.) and LA (0 mg/kg) 
GF+LA(30) (Group 3): Glycerol formal and LA (30 mg/kg, t.i.d. for 2 days) 
PMSF+LA(30) (Group 4): PMSF (90mg/kg,s.c.) and LA (30 mg/kg, t.i.d. for 2 days). 
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Figure 6. Effects of PMSF posttreatment on LA-induced ataxia in 3 week-old chickens. 
LA(O)+GF (Group 5): Control, 
LA(O)+ PMSF (Group 6): LA (0 mg/kg) and post treatment with PMSF (90 mg/kg, s.c.), 
LA(30)+GF (Group 7): LA (30 mg/kg, t.i.d. for 2 days) and Glycerol formal, 
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Days After Treatment 
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Figure 7. Effects of PMSF pretreatment on LA-induced ataxia in 6 week-old chickens. 
LA(O)+GF (Group 5): Control, 
LA(O)+ PMSF (Group 6): LA (0 mg/kg) and post treatment with PMSF (90 mg/kg, s.c.), 
LA(30)+GF (Group 7): LA (30 mg/kg, t.i.d. for 2 days) and Glycerol formal, 
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Days After Treatment 
I-+- LA(O)+GF -- LA(O)+PMSF -am= LA(30)+GF '""*"" LA(30)+PMSF I 
Figure 8. Effects of PMSF posttreatment on LA-induced ataxia in 6 week-old chickens. 
LA(O)+GF (Group 5): Control, 
LA{O)+ PMSF (Group 6): LA (0 mg/kg) and post treatment with PMSF (90 mg/kg, s.c.), 
LA(30)+GF (Group 7): LA (30 mg/kg, t.i.d. for 2 days) and Glycerol formal, 
LA(30)+PMSF (Group 8): LA (30 mg/kg, t.i.d. for 2 days) and PMSF (90mg/kg, s.c.). 
45 
NTE Activity 
Figure 9 shows NTE activities of 3 week-old chickens in PMSF pretreatment 
group. Brain, spinal cord and sciatic nerve of birds in PMSF and PMSF+LA treatment 
groups had a significant reduction of NTE activity compared to control and LA only 
group. However, there was no difference between PMSF only and PMSF+LA groups. 
Birds treated with LA only did not show any difference from control. 
Figure 10 shows NTE activities of 3 week-old chickens in PMSF postreatment 
group. Similarly, birds treated with PMSF and LA+PMSF had a significant reduction in 
NTE activity compared to control. LA only group of N TE activities was not different 
from control. 
Figure 1 1 shows N TE activities o f 6 week-old chickens in P MSF pretreatment 
group. Similar to 3 week-old chickens only PMSF and PMSF+LA treated birds had 
reduced NTE activity. 
Figure 12 shows NTE activities of 6 week-old chickens in PMSF postreatment 
group. Similar to 3 week-old chickens, while groups treated with PMSF only and 
LA+PMSF had reduced NTE activity, no difference was found in LA treated birds 
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Figure 9. Inhibition of neurotoxic esterase (NTE) activity in Brain, Spinal Cord and 
Sciatic Nerve as percent of control in PMSF pretreatment in 3 week-old chickens. 
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NTE Activity of 3 week-old chickens 
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Figure 10. Inhibition of neurotoxic esterase (NTE) activity in Brain, Spinal Cord and 
Sciatic Nerve as percent of control in PMSF postreatment in 3 week-old chickens. 
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Figure 11. Inhibition of neurotoxic esterase (NTE) activity in Brain, Spinal Cord and 
Sciatic Nerve as percent of control in PMSF pretreatment in 6 week-old chickens. 
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Figure 12. Inhibition of neurotoxic esterase (NTE) activity in Brain, Spinal Cord and 
Sciatic Nerve as percent of control in PMSF postreatment in 6 week-old chickens. 
* Indicates significant effect of PMSFcompared to control, p < 0.05 . 
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Motor Nerve Conduction Velocity 
Figure 13 and 14 show average motor nerve conduction velocity of pre- and post 
PMSF treated birds at 3 weeks old age. Mean MNCV s of control birds were 30. 7 ± 2.2 
m/sec (Group 1) and 36.0 ± 4.4 m/sec (Group 5) in 3 week-old birds, respectively. 
MNCV s of groups receiving only PMSF were not different from that of the controls. LA 
treated birds and birds receiving combination of LA and PMSF had decreased MNCVs 
compared to their respective control groups. However, PMSF did not affect MNCVs of 
in LA-treated birds. 
Figure 13 and 14 show average motor nerve conduction velocities of pre- and post 
PMSF treated birds at 6 weeks old age. Six week-old chickens treated with LA or 
PMSF+ LA had significantly reduced M NCV in comparison to the control groups, but 
PMSF did not appear to influence MNCV alone or in combination with LA. Control birds 
at 6 weeks of age had average MNCVs of 34.4 ± 0.7 m/sec and 35.4 ± 2.3 m/sec, 
respectively. Similar to 3 week-old chickens, 6 week-old chickens given only PMSF did 
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Figure 13. Effects of PMSF pretreatment on MNCVs in 3 week-old chickens. 
Mean conduction velocity (mis)± sd * Indicates significant decrease in MNCV compared 



























Figure 14. Effects of PMSF pretreatment on MNCVs in 6 week-old chickens. 
Mean conduction velocity (mis) ± sd * Indicates significant decrease in MNCV 
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Figure 15. Effects of PMSF posttreatment on MNCVs in 3 week-old chickens. 
Mean conduction velocity (mis) ± sd * Indicates significant decrease in MNCV 




























Figure 16. Effects of PMSF posttreatment on MNCVs in 6 week-old chickens. 
Mean conduction velocity (mis) ± sd * Indicates significant decrease in MNCV 
compared to the control, p < 0.05. 
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Light and Electron Microscopic Changes 
Light Microscopy 
Figure 17 and 18 show sciatic nerve from groups treated with LA. Similar to birds 
receiving combination of LA and PMSF, these birds showed vacuolated myelin (voids), 
fragmented axons and digestion chambers. 
Figure 19 shows spinal cord of an ataxic bird treated with LA+PMSF. Lesions in 
the spinal cord included fragmented axons with areas of myelin vacuolations. Three 
week-old birds receiving LA and post treatment of PMSF had lesions in the spinal cord. 
Mild lesions were distributed primarily in the dorsal spinocerebellar tracts, fasiculi 
gracilus and rarely the ventral corticospinal tract. No spinal cord lesions were observed in 
any other groups of LA or LA with PMSF treated birds in either 3 or 6 week-old birds. 
Figure 20 shows sciatic nerve of an ataxic bird treated with LA and PMSF. 
Lesions included vacuolated myelin (voids), fragmented axons and digestion chambers. 
Mean degeneration scores of the sciatic nerve in groups receiving LA and 
combination of LA and PMSF were significantly higher than those of control in 3 and 6 
week-old chickens (Table 3 and 4). No lesions were noted in control or groups receiving 
only PMSF either in the spinal cord or sciatic nerve. 
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Figure 17. Light micrograph of a sciatic nerve from an ataxic bird treated with lasalocid. 
Areas of myelin vacuolation (arrows). (H&E), (Magnification 400x) 
Figure 18. Light micrograph of a sciatic nerve from an ataxic bird treated with lasalocid. 
Foamy myelin vacuoles with axonal fragments (arrows). (H&E), (Magnification, 200x) 
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Figure 19. Light micrograph of a spinal cord from an ataxic bird treated with lasalocid 
and PMSF. Fragmented axon (Arrow). (H&E), (Magnification, 200x) 
Figure 20. Light micrograph of a sciatic nerve from an ataxic bird treated with lasalocid 
and PMSF. Multiple areas of myelin vacuolation (arrows). (H&E), (Magnification, 200x) 
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Table III. Mean degeneration scores in the Sciatic Nerve, Spinal Cord, Brain and Muscle 
of 3 week-old birds. * Indicates significant difference compared to the controls. 
t Indicates significant difference compared to PMSF+LA (30) 
Score Score 
PMSF Tissue (Mean) PMSF Tissue (Mean) 
Pre-Treatment Post-Treatment 
Sciatic N. 0 Sciatic N. 0 
1.GF Spinal C. 0 1. LA (0 mg/kg) Spinal C. 0 
2. LA (Omg/kg) 2.GF 
Brain 0 Brain 0 
Muscle 0 Muscle 0 
Sciatic N. 0 Sciatic N. 0 
1.PMSF Spinal C. 0 1. LA (Omg/kg) Spinal C. 0 
2. LA (Omg/kg) 2. PMSF 
Brain 0 Brain 0 
Muscle 0 Muscle 0 
Sciatic N. 3* t Sciatic N. 2.6* 
1.GF Spinal C. 0 1. LA (30mg/kg) Spinal C. 0 
2. LA (30mg/kg) 2.GF 
Brain 0 Brain 0 
Muscle 0 Muscle 0 
Sciatic N. 1.3* Sciatic N. 2.6* 
1.PMSF Spinal C. 0 1. LA (30mg/kg) Spinal C. 0.6* 
2. LA (30mg/kg) 2. PMSF 
Brain 0 Brain 0 
Muscle 0 Muscle 0.3 
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Table IV. Mean degeneration scores in the Sciatic Nerve (Sciatic N.), Spinal Cord (Spinal 
C.), Brain and Muscle of 6 week-old birds. * Indicates significant difference compared 
to the controls. t Indicates significant difference compared to PMSF+LA (30) 
PMSF Score PMSF Score 
Pre-Treatment Tissue (Mean) Post-Treatment Tissue (Mean) 
Sciatic N. 0 Sciatic N. 0 
1.GF Spinal C. 0 1. LA (0 mg/kg) Spinal C. 0 
2. LA (Omg/kg) 2.GF 
Brain 0 Brain 0 
Muscle 0 Muscle 0 
Sciatic N. 0 Sciatic N. 0 
1.PMSF Spinal C. 0 1. LA (Omg/kg) Spinal C. 0 
2. LA (Omg/kg) 2. PMSF 
Brain 0 Brain 0 
Muscle 0 Muscle 0 
Sciatic N. 2.6* t Sciatic N. 2.0* 
1.GF Spinal C. 0 1. LA (30mg/kg) Spinal C. 0 
2. LA (30mg/kg) 2. GF 
Brain 0 Brain 0 
Muscle 0 Muscle 0 
Sciatic N. 2.0* Sciatic N. 2.3* 
1. PMSF Spinal C. 0 1. LA (30mg/kg) Spinal C. 0 




Muscle 0 Muscle 0 
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Electron Microscopy 
Figure 21 shows an electron micrograph of a sciatic nerve from the control group. 
Cross sections of sciatic nerve from control birds appeared normal. Nerve fibers had 
ovoid or round shape with evenly arranged myelin lamellae. Myelin layers were compact, 
and borders between myelin structure and axon were tightly attached. The axons had 
normal appearance with homogeneous distribution of neurofilaments and microtubules. 
Figure 22 is a section of sciatic nerve taken from an ataxic bird treated with LA 
and PMSF. As figure 22 shows, separation of myelin layers and extensive intramyelinic 
edema were evident. There was also myelin derangement and myelin fragmentation. 
Figure 23 and 24 show electron micrographs from the groups treated with LA and 
PMSF. Prominent vacuolation within myelin layers was observed and the vacuolation 
were in close proximity to the axonal region. The axon was compressed and distorted as a 
result of edema and myelin disruption. The Schwann cell looked normal. In addition, 
tissues surrounding the nerve and Schwann cell appeared normal with evenly distributed 
collagen fibers. 
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Figure 21. Electron Micrograph of a Sciatic Nerve from the control group. Myelin sheath 
(diamond), axon (star) (xl 1,500) 
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Figure 22. Electron Micrograph of a Sciatic Nerve from LA and PMSF treated chicken. 
Vacuoles within myelin (Thick arrow), . Separation of myelin layers and formation of 
edema (Star), and myelin fragmentation (diamond). (x46,000) 
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Figure 23. Electron Micrograph of a Sciatic Nerve from LA and PMSF treated bird. 
Extensive edema (star), myelin vacuolation (arrow), intact compressed axon (Arrow 
head). (x 10,000) 
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Figure 24. Electron Micrograph of the Sciatic Nerve from a LA and PMSF treated birds. 
Myelin fragment (star), intact-compressed axon (Arrow). (x32,000) 
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Discussion: 
A wide range of xenobiotics have been shown to cause neuropathies in man and 
experimental animals. Some organophosphorus toxicants have been known for decades to 
cause neuropathy. Other toxicants including hexacarbons and acrlyamide can cause 
neuropathy through poorly understood mechanisms. Previous studies showed that 
lasalocid (LA) and some other ionophores can cause a neuropathy in chickens through 
facilitation of mono and divalent cation transport across cell membranes (Halvorson et 
al., 1982; Gregory et al., 1995; Roder, 1996; Van der Linde-Sipman et al., 1999). 
PMSF, a serine protease inhibitor, can modify the progression of OPIDN (Johnson, 
1969; Pope and Padilla, 1990; Harp et al 1997) and other forms of neurodegeneration 
(Moretto et al, 1992). The studies presented here show that PMSF may also modulate the 
neuropathy induced by LA. In our studies, LA (30 mg/kg, p.o., t.i.d. for 2 days) induced 
moderate to severe ataxia and death in 3 and 6 week old chickens. Neurotoxic signs of 
LA alone were ataxia, loss of righting reflex, paralysis of hindlimbs and death. Signs of 
neuropathy noted following LA were very similar to those reported by Roder (1996). 
While PMSF pretreatment increased the severity of ataxia in 3 week-old birds, PMSF 
post-treatment did not substantially affect ataxia. The results obtained here are not 
comparable to potentiation of OPIDN by PMSF, because of different time dependent 
effects of PMSF on OPIDN. It was shown that PMSF either prevents or potentiates 
OPIDN depending on the sequence of administration of PMSF. When given prior to OP 
exposure, PMSF protected animals from neurotoxic challenge (Carrington and Abou-
Donia, 1983; Pope and Padilla, 1990; Massicotte et al, 1999), while when given after OP 
exposure, PMSF potentiated OPIDN (Harp et al, 1997; Pope and Padilla, 1990). It was 
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proposed that the protective effect of PMSF is related to prior occupation of the active 
site of NTE thus preventing the neuropathic OP from binding NTE. In the case of 
potentiation, Pope and Padilla (1990) suggested involvement of another PMSF binding 
site which results in modification of subsequent steps in OPIDN or disruption of cellular 
repair process. 
Xu et al., (1999) reported that PMSF significantly increased ataxia induced by p-
bromophenylacetylurea in F-344 rats. Increased toxicity was observed in PMSF 
pretreated rats but not in PMSF post-treated rats. Phenylmethylsulfonyl fluoride 
increased the concentrations of p-brom.ophenylacetylurea and its toxic metabolite 
suggesting that PMSF alters the toxickinetics of p-bromophenylacetylurea, leading to 
increased concentration of the toxicant in tissues. Similarly, we observed more toxicity in 
LA-treated birds with PMSF pretreatment, but lesser or no effect with posttreatment. 
Accordingly, a toxicokinetic interaction between PMSF and LA may be responsible. 
Moretto et al. (1993) reported that following a severe nerve crush in chickens, PMSF pre 
and post treatment delayed the recovery period. The authors speculated that PMSF might 
· interfere with repair machinery in the axons since PMSF did not increase the severity of 
nerve crush but delayed the recovery. Disruption of a repair mechanism by PMSF in the 
case of potentiation of OPIDN and other chemically-induced neuropathies was also 
suggested (Pope and Padilla, 1990: Moretto et al., 1993). 2,5- Hexanedione neuropathy 
was reported to be promoted by PMSF. The putative mechanism of 2,5-Hexanedione 
toxicity (i.e., crosslinking of neurofilaments) differs from that of OPIDN, suggesting 
neuropathies caused by different mechanisms can be promoted by PMSF (Moretto et al., 
1992). 
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Pathologic changes in neuronal tissues in response to LA treatment with or without 
PMSF were interesting in that LA alone did not cause any change in spinal cord or brain, 
but effects were confined to the sciatic nerve only. Effects included vacuole formation in 
myelin, empty spaces filled with fluid due to sequestration and breakdown of cytoplasmic 
component, axon fragmentation and digestion chambers. Such changes are in agreement 
with the findings reported by Gregory et al. (1995) and Roder (1996). While there was no 
change in spinal cord of LA treated birds, PMSF pretreatment led to slight but significant 
cord degeneration in LA-treated birds. 
One of the proposed mechanisms of OPIDN is associated with alteration of 
neurofilament (NF) subunits by OP compounds. It was demonstrated that disopropyl 
phosphofluoride led to the elevation of NF subunit proteins and mRNAs (Xie, et al., 
2001; Xie et al., 2002) and PMSF treatment can modify this effect. It was further 
suggested that PMSF pretreatment could also modifies the expression of some other 
cytoskeletal protein mRNA. This effect was shown in transgenic animals that devoid of 
NFs in their axon (Xie, et al., 2001). This findings indicates that other cytoskeletal 
proteins can be affected by PMSF pretreatment. Therefore, a possible interference with 
cytoskeletal proteins and NF by PMSF might have occurred in the pretreatment of LA-
neurotoxicity leading to increased response as ataxia and increased lesions in the nerve 
fibers. 
Another possible mechanism might be associated with alteration of lysolecithin. 
It was shown that NTE may have lysophospho pholipase activity. Lysophospho pholipase 
hydrolyses lysolecithin as its physiologic substrate which is known to cause myelin 
degredation in nerves. Since PMSF is an NTE inhibitor, inhibition of lysophospho 
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pholipase by PMSF can subsequently lead to accumulation of lysolecithin causing an 
increased response in LA-induced neurotoxicity when given together. However, we 
observed increased response in PMSF pretreatment not in postreated birds. One 
explanation for this effect might be that LA may have already caused damage in the 
nerve fibers so that no additional detrimental effect is caused by PMSF in the progression 
of nerve damage. In contrast, in pretreatment of PMSF, there might be a chance for an 
interaction between PMSF and LA to produce potentiating effect. 
It is also suggested that PMSF might inhibit some cellular events triggered by the 
activation of phospholipase C (PLC), such as activation of phospholipase A2 in ischemia 
(Wang et al., 2001). One of the pathways in LA neurotoxicity is caused by activation 
phospholipase A2 via increased Ca++ overload. In the PMSF postreatment, PMSF 
somehow may have acted somehow on this pathway leading to relatively decreased 
response compared to PMSF pretreatment. 
One can also speculate on toxicokinetic interaction and alteration of repair process. 
PMSF may alter the toxicokinetics of LA so that more LA can reach the tissues including 
spinal cord, with higher LA concentration eliciting spinal cord lesions. PMSF was shown 
to promote p-bromophenylacetylurea neuropathy through toxicokinetic alterations (Xu, et 
al., 1999). Another explanation is that PMSF can alter cellular repair process of 
subclinically affected nerve tissue in LA toxicated birds. Interestingly, the distribution of 
lesions was localized primarily in the dorsal spinocerebellar tracts, fasiculi gracilus and 
the ventral corticospinal tract in the spinal cord which was similar to lesions seen in 
OPIDN (Bouldin and Cavanagh, 1979). 
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Ultrastructural changes included intramyelinic edema, myelin separation and 
vacuolation. These results are similar to previous reports of LA toxicity (Gregory et al., 
1995; Roder, 1996). 
NTE activity of spinal cord, brain and sciatic nerve of LA treated birds showed no 
difference from that of control birds. This is not surprising since LA exerts its toxic effect 
through a mechanism unrelated to NTE inhibition. However, PMSF significantly 
inhibited spinal cord, brain and sciatic nerve NTE activity. 
Motor Nerve Conduction Velocity findings showed that PMSF does not affect 
sciatic nerve conduction velocity in LA treated birds; nevertheless LA causes significant 
reduction of conduction velocity in the sciatic nerve. MNCV values obtained herein are 
very close to Roder's (1996) observations. Robertson and Anderson (1986) reported 
normal nerve conduction velocities of adult hens. The values presented by the authors 
were similar to those of control birds in our study. 
In conclusion, PMSF may potentiate LA-induced peripheral neuropathy and induce 
spinal cord lesions when given with LA in broiler chickens. The mechanism for spinal 
cord lesions and exacerbation of ataxia warrants further investigation. 
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NEUROTOXICITY OF LASALOCID AND EFFECTS OF PHENYL 
METHYL SULFONYL FLUORIDE IN MALE SPRAGUE DAWLEY RATS 
Abstract 
Lasalocid toxicity has been associated with several neurotoxicity cases in animal 
species. Unpublished field reports indicated that incidence of lasalocid neurotoxiciy 
shows a higher rate in chickens during heat stress with increased water salinity. Male 
Sprague Dawley rats were given 0, 10, 20, 40 mg/kg of lasalocid two times a day for 3 
days with or without 0.9 % saline in the drinking water. Additional rats were given 20 
mg/kg lasalocid two times a day for 3 days before phenylmethylsulfonyl fluoride (PMSF) 
treatment. Lasalocid neuropathy and modulation by PMSF were evaluated using an ataxia 
scoring system and histopathology. Rats showed ataxia in the 20 and 40 mg/kg dose 
groups with higher death rate in group receiving 40 mg/kg of lasalocid. Dietary salt did 
not affect ataxia induced by lasalocid. Rats responded to lasalocid+PMSF treatment with 
a higher ataxia than the lasalocid only group. PMSF may potentiate neuropathy induced 
by lasalocid. While the optimum dose to produce ataxia (without high mortality) appears 




Ingestion of cat food which was accidentally contaminated with the ionophore 
salinomycin resulted in outbreak of acute polyneuropathy in the Netherlands in 1996 
(Van der Linde-Sipman et al., 1999). Clinical symptoms of the affected cats were acute 
lameness and paralysis ofhindlimbs followed by forelimbs. Histopathologic examination 
of the affected cats showed that peripheral nerves of both hind- and forelimbs were 
affected. The changes included swelling, fragmentation and loss of axon and digestion 
chambers in myelin (Van der Linde-Sipman et al., 1999). Furthermore, Gregory et al 
(1995) reported that chickens fed a ration containing LA under heat-stressed conditions 
had lesions in the sciatic nerve including swollen and shrunken axons and also vacuole 
formation in the myelin sheath. 
Several studies reported toxic effect of ionophores in rodent species. Gad et al 
(1985) reported that some ionophores including LA caused central and peripheral 
nervous system effects leading to tonic and clonic convulsions and aggressive behaviors 
in CD-1 mice and Fisher 344 rats. 
Phenylmethylsulfonyl floride (PMSF) can modulate certain neuropathies. A well 
known example of this effect is seen in organophosphate induced delayed neuropathy 
(OPIDN). Phenylmethylsulfonyl floride is a serine protease inhibitor which has been 
utilized to elucidate organophosphate induced delayed neuropathy (OPIDN) (Lotti, 
1992). Besides OPIDN, PMSF can also potentiate p-Bromophenylacetylurea induced 
neuropathy in rats (Xu, et al., 1999) and delays the recovery from nerve crush (Moretto, 
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et al., 1993). Therefore, we investigated a possible interaction between LA and PMSF in 
rats. 
The main hypothesis of this study was that LA induces peripheral neuropathy, and 
PMSF exacerbates the neurotoxic effect of LA in rats. To determine the dose given by 
oral route that causes the neurotoxic syndrome in rats by LA, dose response study was 
performed. In addition, there are some reports that indicate dietary levels ofK+ and some 
other ions might influence ionophore toxicity (Halvorson, 1982). In the poultry industry, 
it is known that incidence of LA toxicosis is higher during the hot summer period with 
increased water salinity (VanHooser personal observations). With the combination of 
environmental stress factors, increased temperature and water deprivation may play a role 
for higher rate of LA neurotoxicity and cardiotoxicity (Gregory et al., 1995). Therefore, 
we investigated also the effect of 0.9 % NaCl in drinking water on LA toxicity in rats. 
Materials and Methods 
Materials: 
All materials including Lasalocid A Sodium salt (purity '?.97 %), PMSF, dimethyl 
sulfoxide (DMSO), glycerol formal (GF) were purchased from Sigma Chemical 
Company, St. Louis, MO. Lasalocid was dissolved in DMSO (vehicle for LA) at a 
concentration of 10 mg/ml. Phenylmethylsulfonyl fluoride was dissolved in GF (vehicle 
for PMSF) at a concentration of 90 mg/ml. Saline solution (0.9 %) was prepared with 
deionized water. 
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Animals and Treatment: 
Characterization of O ral D ose R espouse and Effect o f D ietary S alt on L asalocid 
Toxicity in Sprague Dawley Rats 
Thirty two male Sprague Dawley rats with approximate body weight 175-200 g. 
( 46-49 day-old) were obtained from a commercial source (Harlan, Oregon, WI). All rats 
upon arrival were acclimatized 7 days before the start of experiment and food and water 
were provided ad libitum. Following the acclimatization period, the rats were divided into 
8 groups containing 4 rats each. Two days before the experiment, water was discontinued 
and 0.9 % NaCl solution was given to groups 2, 4, 6, and 8 until the end of experiment. 
On the day of dosing, all rats were weighed and doses of LA were given orally according 
to the design below (Table V). 
Four different doses of LA including 0, 10, 20, and 40 mg/kg 2 times a day for 3 
days, with or without 0.9 % NaCl in the drinking water were used. 
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Table V. Experimental design: Treatment groups in Characterization of Oral Dose 
Response and Effect of Dietary Salt on lasalocid toxicity in Sprague Dawley Rats in male 
Sprague Dawley rats 
Group # of rats Treatment 
1 4 LA (0 mg/kg) in DMSO 2 times for 3 days + normal water 
2 4 LA (0 mg/kg) in DMSO 2 times for 3 days + 0.9 % NaCl 
3 4 LA (10 mg/kg) in DMSO 2 times for 3 days + normal water 
4 4 LA (10 mg/kg) in DMSO 2 times for 3 days+ 0.9 % NaCl 
5 4 LA (20 mg/kg) in DMSO 2 times for 3 days + normal water 
6 4 LA (20 mg/kg) in DMSO 2 times for 3 days + 0.9 % NaCl 
7 4 LA ( 40 mg/kg) in DMSO 2 times for 3 days + normal water 
8 4 LA (40 mg/kg) in DMSO 2 times for 3 days+ 0.9 % NaCl 
LA-induced neuropathy and effects of PMSF in male Sprague Dawley rats 
Twenty four male Sprague-Dawley rats with approximate body weight of 175-210 
grams (46-48 day-old) were obtained from Harlan (Oregon, WI). The rats were housed in 
groups of 2 and allowed to adapt to the environment for at least 1 week prior to dosing. 
Feed and water were provided ad libitum. Following the acclimatization period, the rats 
were randomly divided into 4 groups containing 6 rats each. Table VI shows the 
treatment groups. 
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Table VI. Treatment groups in LA-induced neuropathy and effects of PMSF in male 
Sprague Dawley rats. 
Group 
1 (Control) 
2 (PMSF only) 








LA* (0 mg/kg, oral gavage) + PMSF* (0 mg/kg, s.c.) 
LA* (0 mg/kg, oral gavage) + PMSF (90 mg/kg, s.c.) 
LA (20 mg/kg, oral gavage) + PMSF* (0 mg/ml, s.c.) 
LA (20 mg/kg, oral gavage) + PMSF (90 mg/kg, s.c.) 
* DMSO and GF (vehicles) were used as LA (0 mg/kg) and PMSF (0 mg/kg), 
respectively. 
Group 4 and 3 received 20 mg/kg of LA with or without PMSF, respectively. These 
groups were treated with 20 mg/kg of LA (in DMSO) by oral gavage 2 times a day for 3 
days. Four hours following the final LA application, a single dose of PMSF (90mg/kg, 
s.c., in GF) or GF only was administered, respectively. Group 2 received DMSO (0.1 ml 
per 100 g. of body weight) by oral gavage 2 times a day for 3 days. Four hours following 
last DMSO application, a single dose of PMSF (90mg/kg, s.c., in GF) was administered. 
Group 1 was treated with vehicles only and served as control. 
Clinical Observations 
Starting from day 1, all rats were observed daily 2 times a day until they were 
sacrificed ( day 8). All treatment groups were evaluated for the development of ataxia and 
behavioral changes. Individual rats were graded "blind" to assign an ataxia score. Each 
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rat was placed on the ground and allowed to acclimate to the environment for a couple of 
minutes. Then the rats were observed without further disturbance for behavioral changes. 
To determine gait abnormalities and degree of ataxia, the rats were allowed to move 
freely. Then they were forced to walk to detect slight ataxia and to determine if the 
degree of ataxia increased. Ataxia scores were given according to clinical ataxia scoring 
system {Table VII). 










Slight ataxia after exercise 
Slight ataxia, ataxia worsens after exercise 
Ataxic rats 
Non-ambulatory, alert 
Non-ambulatory, not alert, depressed 
Determination of Foot Splay 
Spreading of hind limbs was measured in all rats in each treatment group. 
Determination of foot splay was carried out by the method of Edwards and Parker 
(1977). Briefly, both feet were pressed onto an inkpad, and the rat was held horizontally 
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in dorso-ventral position with the body 32 cm above the surface of a table. The rat was 
then released from the top, and the distance between the ink marks was measured upon 
landing. The procedure was repeated 3 times for each rat and the average of 3 readings 
was used. 
Histopathologic Examinations 
Light Microscopy: Three rats from each group were randomly selected for necropsy and 
histopathologic and ultra structural studies. The rats were killed in a CO2 chamber. The 
sciatic nerve and the entire spinal cord were dissected and fixed in 2.5 % buffered 
glutaraldehyde. The brain and sections of skeletal muscle were taken and placed in 
fixative. Sections for histopathologic examination were embedded in paraffin, cut 4-6 µm 
thick and stained with hematoxylin and eosin (H&E). Selected sections of sciatic nerves 
and spinal cord were also stained with Severe-Munger and counterstained with Luxol 
Fast Blue. All sections of tissue were examined by light microscopy and lesions scored 




0 - No lesions 
1 - Swollen axons, foamy vacuolation of myelin 
2 - Small distinct random vacuoles (Voids) in myelin 
3 - Distinct vacuoles in myelin with atrophy and/or fragmentation of axons 
4 - Large distinct myelin vacuoles (Voids), digestion chambers (axon-myelin debris), or 
loss of axons. 
Spinal Cord Lesions: 
0 - No lesions 
1 - Small number of degenerating axons 
2 - Moderate number of degenerating axons 
3 - Numerous degenerating axons 
Electron Microscopy: Sciatic nerves from affected rats were fixed in a 
glutaraldehyde/formalin mixture. Nerve pieces were washed with 0.1 M cacodylate 
buffer three times for 20 minutes. Gross transverse slices of the nerve segments were cut. 
The tissues were post-fixed in 1 % cacodylate buffered osmium for two hours then 
washed three times in 0.1 M cacodylate buffer. After post-fixation, the tissues were 
dehydrated by graded ethanol series (50, 70, 90, 95, 100) and washed three times with 
propylene oxide for 20 minutes. The tissues were put into 1 : 1 propylene oxide/hard 
polybed and polymerized a 60 ° C for 48 hours. Blocks of the nerve pieces were thick-
sectioned and areas of interest were subsequently processed for thin sectioning. Thin 
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sections of samples were examined usmg a JEOL 100 CX transmission electron 
microscope at 80 KV. 
Data Analysis: 
Data were analyzed using one-way analysis of variance (ANOV A) with a general 
linear model (GLM) using SAS. For ataxia scores, group data are presented as 
medians±inter quartile range calculated as 75th percentile minus 25th percentile of data. 
For all other endpoints, group data are presented as means. Differences among 
experimental groups were attained using LSD multiple comparison test. Significance 
level of0.05 was used for comparisons of treatments. 
Results 
Clinical Signs and Ataxia in Characterization of Oral Dose Response and Effect of 
Dietary Salt in Sprague Dawley Rats 
Figure 25 depicts the median ataxia scores in the characterization of oral dose 
response and effect of dietary salt on lasalocid toxicity in male Sprague Dawley rats. Rats 
in control groups (0 mg/kg of LA with or without 0.9 % NaCl solution) appeared normal 
clinically. All rats in these groups were active and alert, and showed no behavioral 
changes or gait abnormalities. No mortality was observed. While only one rat (LA (10 
mg/kg in DMSO 2 times for 3 days + 0.9 % NaCl ) in 10 mg/kg LA dose-group showed 
ataxia with the score of 2, remaining rats in this dose group appeared normal (Figure 25). 
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Some rats treated with 20 and 40 mg/kg of LA with or without 0.9 % NaCl solution 
(Group 5, 6, 7 and 8) developed ataxia. Ataxia was more prominent in groups treated 
with 40mg/kg LA with or without 0.9 % NaCl solution. Some rats in these groups 
developed diarrhea following the next day ( day 2) of LA treatment. Clinically affected 
rats were reluctant to move and less active compared to controls and the rats given 10 
mg/kg LA with or without NaCl. Rats with ataxia scores 4 had difficulty to stay erect side 
of body with no righting reflex. Rats in this condition were unable to move hind limbs; 
however they attempted to move with front legs. While no mortality was seen in groups 
receiving 10 or 20 mg/kg LA with or without 0.9 % NaCl solution, groups receiving 
highest dose of LA with or without NaCl showed high mortality (3/4, 2/4 respectively). 
Figure 26 shows the results from the evaluation of foot-splay after treatment with 
LA in different dose groups with or without NaCl. No difference was noted between 
control rats and the treatment groups. Mean foot-splay values of ataxic birds were similar 
to the controls and were not affected by the treatment. 
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Figure 25. Median Ataxia Scores in Characterization of Oral Dose Response and Effect 
of Dietary Salt on Lasalocid toxicity in male Sprague Dawley Rats, (n=4). Data are 
shown as median ataxia scores± interquartile ranges (calculated as 75th percentile minus 
25th percentile of the data). 
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Figure 26. Mean Foot-Splay values in Characterization of Oral Dose Response and Effect 
of Dietary Salt on lasalocid toxicity in male Sprague Dawley Rats, (n=4). 
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Clinical Signs and Ataxia in La-induced neuropathy and effects of PMSF on 
Lasalocid Toxicity in male Sprague Dawley rats 
Figure 27 shows the results from LA and LA+PMSF study. Rats in control and 
PMSF only treatment were clinically normal, and the rats in these groups showed no 
signs of ataxia ( one rat in PMSF only group was scored as slightly ataxic at the beginning 
of study). Figure 28 shows the number of rats showing ataxia in each treatment group. 
Some rats in groups treated with LA+PMSF and LA only responded to the drug 
treatment by showing slight to moderate ataxia ( ataxia scores ranging from O to 2) 
(Figure 27). None of the rats in these groups showed full-blown ataxia (ataxia scores of 
3-5). Ataxic rats exhibited weakness, decreased righting reflex, very slow movement and 
loss of grip in hind limbs. Based on median ataxia scores, group receiving LA+PMSF 
treatment had statistically higher median ataxia scores compared to the other groups. 
Rats with clinical ataxia score 1 were able to walk and right themselves when placed on 
dorsal position. When they were forced to walk for a while they showed slight ataxia with 
imbalance in their walking pattern. These rats also were able to react pain stimuli. 
Likewise rats with ataxia score 2 were able to walk and right themselves when placed on 
their dorsum, but they had weakness and slight difficulty to right themselves. When they 
were placed on the ground, they were reluctant to move and had slight disturbance in 
their walking behavior. The ataxia was worsened when the rats in this category were 
forced to walk for several minutes. In addition, when the rats were tested for grip strength 
a decrease in hind limps was observed. Grip strength was normal in front legs. These rats 
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also responded painful stimuli like control rats. In addition, rats treated with LA and 
LA+PMSF showed slight diarrhea, loss of appetite and decreased body weight. 
Figure 29 depicts number of deaths in treatment groups. There was no mortality in 
PMSF only group while 1 out of 6 rats in control was lost during the experiment. Two 
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Figure 27. Median Ataxia Score in LA-induced neuropathy and effects of PMSF in male 
Sprague Dawley. (LA Only: 20 mg/kg LA 2 times a day for 3 days, LA+PMSF: 20 
mg/kg LA 2 times a day for 3 days plus 90 mg/kg single dose of PMSF 4 hours after LA 
dosing). Data are shown as median ataxia scores ± interquartile ranges (calculated as 75th 
percentile minus 25th percentile of the data) . Asterisk indicates significant effect, at p < 
0.05 
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Figure 28 . Frequency Distribution of Rats Showing Ataxia in LA-induced neuropathy 
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Figure 29. Number of deaths in treatment groups in LA-induced neuropathy and effects 
of PMSF in male Sprague Dawley rats (n=6 per group). 
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Foot Splay Study 
Figure 30 shows mean foot-splay distance in LA-induced neuropathy and effects 
of PMSF on lasalocid toxicity in male Sprague Dawley rats. Mean foot-splay technique 
did not discriminate degree of neuropathy and also did not reveal clear indication of 
neuropathy when the values of foot-splay assay were compared to those of control. Based 
on mean distance between the hindlimbs upon landing, there was no significant 
difference among the treatment groups. Although there was a decrease in mean foot-splay 
in rats treated with LA and PMSF compared to control rats, the difference between group 
























































Figure 30. Mean foot splay distance in LA-induced neuropathy and effects of PMSF on 




Figure 31 shows a light micrograph of a sciatic nerve from an ataxic rat treated 
with lasalocid (20mg/kg 2 times a day for 3 days). Lesions were minimal and consisted of 
random vacuolation of myelin sheets. No spinal cord lesions were noted in any treatment 
groups at the light microscopic level. 
Figure 32 shows a light micrograph of muscle tissue from a rat treated with 
lasalocid (40 mg/kg 2times a day for 3 days) and 0.9 % NaCl in drinking water. Mild 
necrosis of skeletal muscle was observed. In the affected areas, loss of striation, 
fragmentation, h ypertrophic satellite cells and edema between m yo fibers were present. 
Muscle lesions were only present in groups treated with the highest dose group of 
lasalocid (40 mg/kg) with 0.9 % NaCl in drinking water. No muscle lesions were 
observed in any other groups. 
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Figure 31. Light micrograph of a sciatic nerve from an ataxic rat treated with lasalocid. 
Vacuolation of myelin sheath (Arrow). (H&E), (x 200) 
Figure 32. Light micrograph of a muscle tissue from a rat treated with lasalocid ( 40 
mg/kg 2times a day for 3 days) and 0.9 % NaCl in drinking water. Necrosis of the tissue 
with loss of striation and fragmentation of myofibers (Arrows). (H&E), (x 200). 
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Electron Microscopy: 
Figures 33 and 34 show electron micrographs of sciatic nerves from the control. 
As noted from the micro graphs, cross section of the sciatic nerve showed no abnormality 
in structure. The myelin sheath was compact with evenly arranged structural appearance. 
Likewise, axons and the Schwann cells were also normal. 
Figure 35 shows an electron micrograph of a sciatic nerve from a rat treated with 
PMSF only. Similar to the control rats, no abnormalities were noted in the sciatic nerve. 
The myelin sheath, axons and the Schwann cells were intact. They showed no difference 
from the control. 
Figures 36, 37 and 38 are micrographs of the sciatic nerves from rats treated with 
lasalocid only. Lesions included splitting of myelin sheet with edema, fragmentation and 
vacuolation of the myelin. As noted from Figures 36 and 37, myelin separation and 
vacuole formation were generalized across the myelin lamellae. In Figure 38, myelin 
appears as fragmented and the pieces of these myelin fragments were also filled with 
vacuolations. 
Figures 39, 40 and 41 are micrographs of the sciatic nerve sections taken from 
rats treated with lasalocid and PMSF. Lesions were similar to the rats treated with 
lasalocid only. Similarly, vacuolation and myelin fragmentation (Figure 39) were present 
in sections. However, as seen in Figure 40, areas of pale myelin were noted in this group 
suggesting loss of myelin and lipid. The axons and Schwann cells did not show an 
abnormality except for a slightly compressed and distorted appearance. Figure 41 shows 
slight fragmentation of myelin. 
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Figures 42 and 43 are from the spinal cord of control rats. No abnormality was 
seen in nerves of the spinal cord. The myelin sheath appeared as successively wrapped 
and evenly compacted layers. The axon and the Schwann cells looked normal also . 
. Figure 44 is from the spinal cord of rats treated with PMSF only. Similar to 
control no change was seen in the appearance o f nerves and the nerve section 1 ooked 
normal. 
Figures 45, 46, 47 and 48 show micro graphs of spinal cord taken from rats treated 
with LA only. As noted from the micrographs, extensive myelin splitting was observed, 
and almost all nerve fibers appeared to be affected by myelin splitting in the sections. The 
axons and Schwann cells were normal and showed no difference from the control. 
Figures 49, 50 and 51 are from the spinal cord of LA+PMSF treated rats. A 
greater degree of myelin separation was seen in small nerve fibers (Figure 49). There was 
also extensive edema between myelin layers and some small nerve fibers appeared to lose 
their axon. The space of axon appeared to be filled by fluid and myelin layers (Figure 
50). Similarly, myelin separation and edema between myelin layers are present in figure 
51. 
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Figure 33 . Electron micrograph of a sciatic nerve from a control rat in the study of 
lasalocid induced neuropathy and effect of PMSF in male Sprague Dawley rats. Note 
the compact evenly arranged myelin sheath (arrows). (x 9000) 
0 
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Figure 34. Electron micrograph of a sciatic nerve from a control rat in the study of 
Lasalocid induced neuropathy and effect of PMSF in male Sprague Dawley rats. Myelin 
sheath (arrow), axon (star) and the Schwarm cell (diamond). (x 24,700) 
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Figure 35. Electron micrograph of a sciatic nerve from PMSF only rat in the study of 
Lasalocid induced neuropathy and effect of PMSF in male Sprague Dawley rats. Myelin 
sheath (arrow), axon (star) and the Schwann cell (diamond). (x 10,000). 
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Figure 36. Electron Micrograph of a sciatic nerve from lasalocid only rat in Lasalocid 
induced neuropathy and effect of PMSF in male Sprague Dawley rats. Note the myelin 
fragmentation and separation (arrows). (x 28,500). 
Figure 3 7. Electron Micrograph of a sciatic nerve from lasalocid only rat in Lasalocid 
induced neuropathy and effect of PMSF in male Sprague Dawley rats. Myelin 
vacuolation and separation (arrows). (x 10,000). 
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Figure 38. Electron micrograph of a sciatic nerve from a rat treated with LA only in the 
study of lasalocid induced neuropathy and effect of PMSF in male Sprague Dawley rats. 
Note the myelin fragmentation (star), and vacuolation (arrows). (x 27,700). 
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Figure 39. Electron micrograph of a sciatic nerve from a rat treated with LA+PMSF in 
the study of lasalocid induced neuropathy and effect of PMSF in male Sprague Dawley 
rats. Note the myelin vacuolation (arrows). (x 41 ,000). 
Figure 40. Electron micrograph of a sciatic nerve from a rat treated with LA+PMSF in 
the study of lasalocid induced neuropathy and effect of PMSF in male Sprague Dawley 
rats. Note the pale areas on myelin sheath (PA), axon (star), the Schwarm cell (diamond). 
(x 10,400). 
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Figure 41. Electron micrograph of a sciatic nerve from a rat treated with LA +PMSF in 
the study of lasalocid induced neuropathy and effect of PMSF in male Sprague Dawley 
rats. Slight myelin fragmentation (arrows). (x 34,800) 
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Figure 42. Electron micrograph of the spinal cord ( dorsal column) from a control rat in 
the study of lasalocid induced neuropathy and effect of PMSF in male Sprague Dawley 
rats. Myelin sheath (arrows), axons (stars) . (x 15,400) 
Figure 43. Electron micrograph of the spinal cord (dorsal column) from a control rat in 
the study of lasalocid induced neuropathy and effect of PMSF in male Sprague Dawley 




Figure 44. Electron micrograph of the spinal cord ( dorsal column) from PMSF only rat in 
the study of Lasalocid induced neuropathy and effect of PMSF in male Sprague Dawley 
rats. Myelin sheath (arrows). (x 26,000). 
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Figure 45. Electron micrograph of the spinal cord (dorsal column) from a rat treated with 
LA only in the study of lasalocid induced neuropathy and effect of PMSF in male 
Sprague Dawley rats. Note the extensive myelin splitting (arrows), normal axon (star). 
(x 40,000) 
- . 
Figure 46. Electron micrograph of the spinal cord ( dorsal column) from a rat treated with 
LA only in the study of lasalocid induced neuropathy and effect of PMSF in male 
Sprague Dawley rats. Areas of myelin splitting (arrows), axon (star). (x 17,500) 
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Figure 47. Electron micrograph of the spinal cord (dorsal column) from a rat treated with 
LA only in the study oflasalocid induced neuropathy and effect of PMSF in male 
Sprague Dawley rats. Areas of myelin splitting (arrows), (x 18,500). 
Figure 48. Electron micrograph of the spinal cord (dorsal column) from a rat treated with 
LA only in the study of lasalocid induced neuropathy and effect of PMSF in male 
Sprague Dawley rats. Note the extensive myelin splitting (arrows), normal axon (star). (x 
20,000) 
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Figure 49. Electron micrograph of the spinal cord (dorsal column) from a rat treated with 
LA +PMSF in the study of lasalocid induced neuropathy and effect of PMSF in male 
Sprague Dawley rats. Note myelin separation and edema (arrow), axon (star). (x 32,000) 
Figure 50. Electron micrograph of the spinal cord (dorsal column) from a rat treated with 
LA+PMSF in the study of lasalocid induced neuropathy and effect of PMSF in male 
Sprague Dawley rats. Note myelin separation and edema (arrow), (x 45,000) 
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Figure 51. Electron micrograph of the spinal cord ( dorsal column) from a rat treated with 
LA+PMSF in the study of lasalocid induced neuropathy and effect of PMSF in male 
Sprague Dawley rats. Note myelin separation and edema (arrow), (x 77,000) 
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Discussion 
In our studies, LA (20 mg/kg, p.o., 2 times a day for 3 days) induced slight to 
moderate ataxia in rats. At this dose, no mortality was observed and it can be suggested 
that 20 mg/kg of lasalocid given by oral gavage 2 times a day for 3 days is the optimum 
dose to produce ataxia in male Sprague Dawley rats. It is known that incidence of LA 
toxicosis is higher with increased water salinity in broiler chickens during hot summer 
period. With the combination of environmental stress factors, increased temperature and 
water deprivation may play a vital role for higher rate of LA neurotoxicity (Gregory et 
al., 1995). Addition of 0.9 % NaCl in drinking water had no effect on neurotoxicity of 
lasalocid in rats. Although we did not observe any detrimental effect of 0.9 % of NaCl in 
drinking water, the percentage of NaCl used in this study may not be sufficient to 
produce additional effect on lasalocid neurotoxicity. Increasing NaCl ratio or water 
deprivation may be needed to see enhanced toxic response. The field reports indicating 
the effect of increased water salinity on LA neurotoxicity might be related to disruption 
of intracellular elemental composition of Na+ and Ca++. There is increasing evidence to 
indicate that the structural and functional consequences of variety of injury processes to 
target cells might be mediated by a disruption of intracellular distribution of Na+, K+ and 
Ca++ and water regulation (MacKnight, 1987; Trump, 1989). Using electron probe X-ray 
microanalysis, it was demonstrated that a correlation exists between cellular 
morphological structure and elemental composition and water content (Lopachin, et al., 
1990). It has been shown that various types of neuropathies caused by drugs, toxins and 
diabetes can be mediated via disruption of subcellular elemental composition of Na+, K+ 
and Ca++ in the peripheral nerves. It was hypothesized that there is an increase in intra-
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axonal Na+, preceded by an inhibition of Na+-K+-ATPase activity leading to reduced 
conduction of nerve impulses. Furthermore, it was also suggested that accumulation of 
increased axoplasmic Ca++ may be responsible for peripheral nerve axon damage and 
degeneration resulting from several types of injury as it is seen in acrylamide toxicity and 
transection (Lopachin, et al., 1990; 1992a; 1992b; 1994; Lehning, et al., 1996). The 
increased intra-axonal Ca++ is mediated by intracellular Na+ and subsequent influx of 
Ca++ ions through reverse operation ofNa+-Ca++ exchanger (Lehning, 1996). In addition, 
it was shown that in transected nerves, ultrastructural changes are mediated by Na+ and 
Ca++ concentration in the media. Sodium in the media of damaged dendrites causes 
dilation of the Golgi cistemae and increased mitochondrial electron opacity similar to 
neurons incubated with monensin (Emery et al., 1991). 
Based on ataxia scores, PMSF appeared to slightly increase degree of ataxia 
compared to the rats treated with LA only. In the mechanism of PMSF-induced 
modulation of OPIDN, several mechanisms are suggested including inhibition of NTE 
(Johnson, 1970) and alteration of neurofilament (Xie, 2002) subunits. However, several 
studies also reported that alterations in Ca++ homeostasis can be seen in OPIDN. Luttrell 
et al (1993) demonstrated that total Ca++ in homogenates of the sciatic nerves was 
decreased significantly in TOTP-treated hens and it was suggested that at fully developed 
OPIDN the alteration of the Ca++ balance is an indicator of axonopathy in a degenerated 
nerve following injury. Interestingly, two studies showed that when hens were dosed with 
TOCP and leptophos, these two OP compounds led to decreased serum Ca++ levels in OP 
treated hens with signs of OPIDN. However, prior administration of PMSF protected the 
animals from delayed neuropathy and blocked the decrease in serum Ca++ concentration. 
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Furthermore, when PMSF administered following the OP compounds to the hens it 
potentiated OPIDN and caused a decrease in serum Ca++ concentration (Piao et al., 1996; 
Piao et al., 2003). In the same study, it was also shown that Calcicol as calcium tonic 
alleviated the neuropathy when applied before the onset of delayed neuropathy (Piao et 
al., 2003). These results suggest that PMSF can alter Ca++ homeostasis. Lasalocid is 
known to act by facilitating Ca++ movement across membranes. Increase in serum Ca++ 
induced by PMSF in the postreatment can provide increased availability of Ca++ for cells 
to be transferred across membranes. Therefore a possible interaction between LA and 
PMSF might occur on Ca++ homeostasis leading to potentiation of neurotoxicity as it is 
seen in our rat study. 
Another possible mechanism for the potentiation of LA neurotoxicity by PMSF 
could be associated with alteration in neurofilament (NF) subunits in nerve fibers. 
Reduced levels of NF transcripts were found in many neurodegenerative disease 
conditions caused by neurotoxic chemicals (acrylamide, aluminum), nerve injury, aging 
and some other diseases (Alzhemer's disease, Parkinson's disease, diabetes). It has been 
reported that diisopropyl phosphofluoride (DFP), a neuropathic OP, altered NF subunit 
protein level and mRNA expression in hens. However, there was no alteration in PMSF-
protected hens. When applied after DFP, PMSF increased medium molecular weight NF 
and decreased expression of NF subunits in the spinal cord that did not occur in DFP 
alone treatment (Xie et al., 2001; Xie et al., 2002). Similary, PMSF can alter cytoskeletal 
composition of nerve fibers in LA-induced neuropathy leading to increased response as 
ataxia and increased lesions in spinal cord. 
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A recent study demonstrated that NTE may have lysophospho lipase (LysoPLA) 
activity with lysolecithin as its physiological substrate. This effect has been shown in 
mouse brain by replacing phenyl valerate (non-physiological substrate used in NTE 
assay) with lysolecithin. The results showed that delayed neurotoxicants applied to the 
mice inhibited NTE-LysoPLA and NTE same degree, and NTE-LysoPLA inhibition was 
correlated with delayed neurotoxicty. It was concluded that OP-induced delayed toxicity 
could be due to NTE-LysoPLA inhibition resulting in accumulation of lysolecithin. 
Lysolecithin is a membrane 1 ysophospholipid which is hydrolysed by LysoPLA. They 
play some critical roles in phospholipid metabolism for cell survival and function. They 
are also involved in receptor-mediated signal transduction via G protein-coupled 
mechanism. In high concentrations, lysolecithin causes demyelination and axonal lesions 
in nerves (Quistad, et al., 2003). Effect of PMSF on NTE-LysoPLA is unknown. 
However, PMSF is known to be one of the inhibitors of NTE. Therefore, it can be 
expected that inhibiton of NTE-LysoPLA by PMSF is quite possible. We can speculate 
for the mechanism of potentiating effect of PMSF on LA-induced neuropathy based on 
these current findings. It is possible that PMSF may have also inhibited NTE-LysoPLA 
activity in the .membranes of nerves leading to membrane disturbance and altered 
phospholipids composition. This will change membrane permeability characteristics to 
Ca++ with the additional effect of LA which causes Ca++ overload. Since NTE is a 
membrane bound protein, same effect of PMSF on NTE-LysoPLA can be seen in 
membranous organelles such as in mitochondria. The excessive Ca++ overload in 
mitochondria causes uncoupling of oxidative phosphorylation leading to decreased ATP 
production and subsequent disturbance in ionic homeostasis. 
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Pathologic findings in neuronal tissues in response to LA treatment with or without 
PMSF included intramyelinic edema, myelin separation, splitting and vacuolation. These 
results are similar to previous reports of LA toxicity (Gregory et al., 1995; Roder, 1996). 
Myelin splitting can be seen in a variety of toxic and diseases conditions. 
Hexachlorophene, triethyltin, and ionomycin are several examples of chemicals leading 
to myelin splitting associated with myelinopathy (Lennart et al., 1978; Cammer, et al., 
1975). Mechanism underlying this includes alterations in nerve and supporting cells. 
Some myelinopathies (myelin splitting) develop due to axonopathy, swannopathy and 
interstitial edema. Endoneurial edema was suggested in hexachlorophene toxicity due to 
vascular changes. Increased endoneurial fluid pressure leading to endoneurial edema can 
cause also edema within myelin layers. This effect may also be due to direct injury to 
myelin sheets by increasing the permeability of myelin to osmotically active cations 
(Robert, 1994). 
Alterations in composition or expression of myelin basic protein have been associated 
with myelin splitting in several neuropathies. Myelin basic protein is a structural protein 
that plays a role in the compaction of myelin lamellae and serves as an adhesive between 
myelin layers (Veronosi et al., 1992). 
In triethyltin and hexachlorophene neurotoxicity, intramyelinic edema and myelin 
splitting can be related to changes in mitochondrial oxidative phosphorilation. 
Biochemical changes in mitochondria are due to uncoupling of oxidative phosphorilation 
(Graham et al, 1973; Cammer, et al., 1975). Ionophores facilitate concentration 
dependent transport of Na+, K+, and Ca++ across membranes by forming lipid soluble 
structures. This effect accounts for the toxicity of ionophores. Electrically neutral 
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exchange of cations for protons across cell membranes disturbs electrochemical gradient 
across mitochondrial membrane leading to decreased ATP production and increased ATP 
use. Monensin and Salinomycin increase intracellular Na concentration whereas lasalocid 
increases intracytoplasmic K+ and Ca++ concentrations. Therefore, increased ion 
concentration may cause influx of extracellular fluid into cells. This fluid can accumulate 
between myelin layers as edema and vacuole formation. 
The ataxia induced by LA in rats was slight to moderate. However, light and ultra 
structural examination of the sciatic nerve and spinal cord revealed that pathological 
lesions in myelin sheath of nerve fibers were somewhat severe compared to the degree of 
clinical ataxia. The reason for this inconsistency between the degree of ataxia and severe 
pathological lesions might be due to the fact that nuclei of nerve fibers localized in spinal 
cord controlling sciatic nerve to the hindlimbs might be still intact and not damaged. In 
addition, although there was an extensive myelin splitting and vacuolation, myelin sheath 
appeared still intact and no demyelination was present. Therefore, the lesioned myelin 
sheath might have provided some insulation for impulse conduction and the ataxia may 
be reflected as slight or moderate ataxia. However, this seems not to be the case since 
MNCV data from chicken study indicates that nerve conduction velocity was impaired 
due to LA toxicity. Anatomically, movement of avian species depends on two hindlimbs 
and body balance has to be provided on two legs. In contrast, the rats are able to use all 
four limbs for body balance and movement. Therefore, body weight and balance are 
distributed to all four legs. Thus, an even small abnormality in physiological function or 
anatomical structure in their hindlimbs may be manifested clinically as more severe 
ataxia in chickens. 
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In conclusion, the results of our study showed that LA induces ataxia and 
pathological changes in the sciatic nerve and spinal cord of rats. Addition of 0.9 % NaCl 
in drinking water has no effect on ataxia induced by LA. The novel finding of this study 
is that phenylmethylsulfonyl fluoride increases the ataxia in LA-treated rats implying that 
neuropathies of different origin can be potentiated by PMSF. The results of this study do 
not provide information on the exact mechanism of this potentiation. Therefore, future 
studies need to be performed on the mechanism that leads to the potentiating effect of 
PMSF on different types of neuropathies. 
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CHAPTER IV 
SUMMARY AND CONCLUSIONS 
The results of the studies presented in the previous chapters indicate that lasalocid 
(LA) is capable of producing a neuropathy in broiler chickens and rats. In chickens, we 
were able to produce an ataxia by the administration of 30 mg/kg of LA t.i.d. for 2 days. 
Clinical manifestation of the neuropathy was observed as ataxia, loss of righting reflex, 
loss of sensitivity in pain perception in hindlimbs. Using clinical ataxia scoring system, 
the degree of ataxia was evaluated and the ataxia ranged from slight to severe in 
chickens. Administration of phenylmethylsulfonyl fluoride (PMSF) before or after LA 
treatment increased the degree of pathologic changes in broiler chickens. The lesions 
included edema and vacuole formation in myelin sheath, myelin splitting and 
fragmentation. At light microscopic level, while chickens treated with LA +PMSF at 3 
weeks old age showed lesions in the spinal cord, no spinal cord lesions were observed in 
chickens treated with LA only. Pathogenesis of the spinal cord lesions shown (Chapter 2) 
in LA+PMSF treated birds requires further investigations. In addition, neurotoxic 
esterase (NTE) assay showed that although PMSF reduced neurotoxic esterease (NTE) 
activity LA did not have any effect on the NTE activity of sciatic nerve, spinal cord and 
brain in chickens. Motor nerve conduction velocity (MNCV) of the sciatic nerve from 
treatment groups indicated that while LA reduced motor nerve conduction velocity 
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(MNCV) in the sciatic nerve, PMSF did not affect the MNCV either alone or m 
combination of LA. 
In the rat study, dose response study indicated that administration of 20 mg/kg of 
LA 2 times a day for 3 days by gavage produced slight ataxia in male Sprague Dawley 
rats. At this dose, no mortality were observed in the rats, therefore 20 mg/kg of LA is the 
optimum dose to produce ataxia without causing death. Rat studies demonstrated that 
lasalocid-induced neurotoxicity may provide a useful mammalian model of drug-induced 
neuropathy. Addition of 0.9 % NaCl in drinking water did not affect ataxia and nerve 
pathology. However, high dose of LA (40 mg/kg) with 0.9 % NaCl produced muscle 
lesions including mild necrosis of skeletal muscle with loss of striation and edema 
between myofibers. 
In the potentiation study, PMSF worsened the ataxia in LA-treated rats. Electron 
microscopic examination of the sciatic nerve and spinal cord demonstrated that LA 
causes lesions including myelin splitting, edema between myelin lamellae, vacuole 
formation in the myelin sheath. 
The consistent finding of PMSF effect on LA-toxicity in both chickens and rats is 
that PMSF potentiates LA-neurotoxicity and produces similar pathological lesions in the 
sciatic nerve and spinal cord. 
The mechanism of lasalocid induced pathologic lesions is unknown. However, 
role of ionophores in the alteration of cellular ionic balance supposedly is the resultant 
effect of i onophore toxicity for these changes. Additional mechanistic studies must be 
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